,drug,MoA,GDSC,CTRP,CCLE,DiSCoVER,CMAP,evidence,DiSCoVER rank,CMAP rank,Average rank
alectinib,gdsc_Alectinib,"ALK inhibitor, used to treat non-small-cell lung cancer (NSCLC)",0.6859999999999999,,,0.686,,+...,1,175,1.0
gsk1070916,gdsc_GSK1070916,Not Clinically Relevant,0.6459999999999999,,,0.646,,+...,2,176,2.0
tl-2-105,gdsc_TL-2-105,Not Clinically Relevant,0.626,,,0.626,,+...,3,177,3.0
sb52334,gdsc_SB52334,Not Clinically Relevant,0.625,,,0.625,,+...,4,178,4.0
cladribine,cmap_cladribine,"purine analog, inhibits adenosine deaminase, which interferes with DNA sythesis. Used for leukemia",,,,,0.95,...+,674,4,4.0
ql-xii-61,gdsc_QL-XII-61,Not Clinically Relevant,0.623,,,0.623,,+...,5,179,5.0
jnj-26854165,cmap_jnj-26854165,"(JNJ-26854165) Mdm2 antagonist, stabilizes p53",,,,,0.945,...+,675,5,5.0
gsk-461364,cmap_gsk-461364,"Plk1 inhibitor, less active against Plk2 and Plk3.",,,,,0.9440000000000001,...+,676,6,6.0
gsk429286a,gdsc_GSK429286A,Not Clinically Relevant,0.603,,,0.603,,+...,6,180,6.0
vx-702,gdsc_VX-702,Not Clinically Relevant,0.574,,,0.574,,+...,7,181,7.0
carmofur,cmap_carmofur,"derivative of fluorouracil, pyrimidine analog",,,,,0.937,...+,678,7,7.0
tubastatin a,ctrp_tubastatin A,Not Clinically Relevant,0.632,0.467,,0.55,,++..,9,182,9.0
amsacrine,cmap_amsacrine,"Intercalator, inhibits Topo II and blocks both DNA replication and transcription, used in ALL",,,,,0.932,...+,679,9,9.0
bx-912,gdsc_BX-912,Not Clinically Relevant,0.541,,,0.541,,+...,10,183,10.0
raltitrexed,cmap_raltitrexed,"antimetabolite,  inhibitor of thymidylate synthase",,,,,0.925,...+,680,10,10.0
rucaparib,gdsc_Rucaparib,"PARP inhibitor, inhibits DNA repair",0.503,,,0.503,0.934,+..+,13,8,10.5
gw-2580,gdsc_GW-2580,Not Clinically Relevant,0.51,,,0.51,,+...,12,184,12.0
thiotepa,cmap_thiotepa,"alkylating agent, ethylenimine family, causes crosslinks in DNA, which prevents DNA replication and DNA transcription",,,,,0.917,...+,681,13,13.0
amuvatinib,gdsc_Amuvatinib,Not Clinically Relevant,0.5,,,0.5,,+...,14,185,14.0
xmd14-99,gdsc_XMD14-99,Not Clinically Relevant,0.499,,,0.499,,+...,15,186,15.0
barasertib,ctrp_barasertib,highly selective Aurora B kinase inhibitor,,0.43,,0.43,0.9790000000000001,.+.+,28,2,15.0
gsk319347a,gdsc_GSK319347A,Not Clinically Relevant,0.46799999999999997,,,0.468,,+...,17,187,17.0
hg-5-88-01,gdsc_HG-5-88-01,Not Clinically Relevant,0.467,,,0.467,,+...,18,188,18.0
xmd13-2,gdsc_XMD13-2,Not Clinically Relevant,0.45899999999999996,,,0.459,,+...,19,189,19.0
exemestane,cmap_exemestane,"aromatase inhibitor, blocks conversion of androgens to estrogens",,,,,0.8185,...++,683,20,20.0
cil55,ctrp_CIL55,Not Clinically Relevant,,0.452,,0.452,,.+..,20,190,20.0
isoliquiritigenin,ctrp_isoliquiritigenin,Not Clinically Relevant,,0.445,,0.445,,.+..,21,191,21.0
altretamine,cmap_altretamine,alkylating antineoplastic agent,,,,,0.818,...+,684,21,21.0
raloxifene,cmap_raloxifene," selective estrogen receptor modulator (SERM), has estrogenic actions on bone and anti-estrogenic actions on uterus and breast",,,,,0.813,...+,685,22,22.0
avrainvillamide,ctrp_avrainvillamide,Not Clinically Relevant,,0.444,,0.444,,.+..,22,192,22.0
sotrastaurin,ctrp_sotrastaurin,pan-PKC inhibitor,,0.44299999999999995,,0.443,,.+..,23,193,23.0
brd-k88742110,ctrp_BRD-K88742110,Not Clinically Relevant,,0.44,,0.44,,.+..,24,194,24.0
ispinesib mesylate,gdsc_Ispinesib Mesylate,Not Clinically Relevant,0.435,,,0.435,,+...,25,195,25.0
iobenguane,cmap_iobenguane,"radiopharmaceutical, radiolabeled molecule similar to noradrenaline",,,,,0.7829999999999999,...+,686,26,26.0
cct036477,ctrp_CCT036477,Not Clinically Relevant,,0.433,,0.433,,.+..,26,196,26.0
brd-k34485477,ctrp_BRD-K34485477,Not Clinically Relevant,,0.433,,0.433,,.+..,27,197,27.0
escitalopram,cmap_escitalopram,Selective Serotonin Reuptake Inhibitor (SSRI),,,,,0.762,...+,687,28,28.0
brd-k99006945,ctrp_BRD-K99006945,Not Clinically Relevant,,0.425,,0.425,,.+..,29,198,29.0
anagrelide,cmap_anagrelide,"phosphodiesterase inhibitor, inhibits maturation of platelets, used for CML",,,,,0.757,...+,688,30,30.0
brd-k51490254,ctrp_BRD-K51490254,Not Clinically Relevant,,0.424,,0.424,,.+..,30,199,30.0
abt-737,ctrp_ABT-737,Bcl-2/Bcl-xL inhibitor,,0.408,,0.408,0.841,.+.+,41,19,30.0
staurosporine,ctrp_staurosporine,Not Clinically Relevant,,0.419,,0.419,,.+..,31,200,31.0
tg100-115,cmap_tg100-115,PI3Kγ/δ inhibitor,,,,,0.737,...+,689,31,31.0
talazoparib,gdsc_Talazoparib,Not Clinically Relevant,0.418,,,0.418,,+...,32,201,32.0
sb-505124,gdsc_SB-505124,Not Clinically Relevant,0.415,,,0.415,,+...,33,202,33.0
formestane,cmap_formestane,"steroidal, selective aromatase inhibitor, used for ER+ Breast cancer",,,,,0.708,...+,690,33,33.0
brd-k26531177,ctrp_BRD-K26531177,Not Clinically Relevant,,0.414,,0.414,,.+..,34,203,34.0
prima-1-met,ctrp_PRIMA-1-Met,Not Clinically Relevant,,0.414,,0.414,,.+..,35,204,35.0
mln-4924,cmap_mln-4924,"(MLN4924), inhibitor of NEDD8-activating enzyme (NAE)",,,,,0.674,...+,692,36,36.0
bms-195614,ctrp_BMS-195614,Not Clinically Relevant,,0.413,,0.413,,.+..,36,205,36.0
sitagliptin,ctrp_sitagliptin,"used for Treating type 2 diabetes, works by increasing the amount of insulin released by your body",,0.384,,0.384,0.8859999999999999,.+.+,57,16,36.5
mitotane,cmap_mitotane,"steroidogenesis inhibitor, cytostatic drug used in the treatment of adrenocortical carcinoma ",,,,,0.6609999999999999,...+,694,38,38.0
indisulam,ctrp_indisulam,"carbonic anhydrase inibitor and  CDK inhibitor, targets G1 by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2",,0.41100000000000003,,0.411,,.+..,38,206,38.0
compound 7d-cis,ctrp_Compound 7d-cis,Not Clinically Relevant,,0.41,,0.41,,.+..,39,207,39.0
mercaptopurine,cmap_mercaptopurine,"purine antagonist, competes with hypoxanthine and guanine for the enzyme HGPRT",,,,,0.631,...+,696,40,40.0
skepinone-l,ctrp_skepinone-L,Not Clinically Relevant,,0.408,,0.408,,.+..,40,208,40.0
vemurafenib,cmap_vemurafenib,BRAF (V600E) inhibitor,,,,,0.562,...+,697,41,41.0
alisertib,ctrp_alisertib,Aurora A kinase inhibitor,,0.368,,0.368,0.975,.+.+,80,3,41.5
brd-k13999467,ctrp_BRD-K13999467,Not Clinically Relevant,,0.406,,0.406,,.+..,42,209,42.0
olaparib,ctrp_olaparib,PARP Inhibitor,0.43,0.395,,0.412,0.49700000000000005,++.+,37,47,42.0
capecitabine,cmap_capecitabine,"Capecitabine is metabolised to 5-FU, a thymidylate synthase inhibitor, which inhibits DNA synthesis",,,,,0.545,...+,698,42,42.0
ml050,ctrp_ML050,Not Clinically Relevant,,0.405,,0.405,,.+..,43,210,43.0
brd-k51831558,ctrp_BRD-K51831558,Not Clinically Relevant,,0.405,,0.405,,.+..,44,211,44.0
axitinib,ctrp_axitinib,"VEGFR, c-KIT and PDGFR inhibitor",0.5379999999999999,0.409,,0.473,0.182,++.+,16,74,45.0
brd-k24690302,ctrp_BRD-K24690302,Not Clinically Relevant,,0.40399999999999997,,0.404,,.+..,45,212,45.0
on-01910,cmap_on-01910,"ON-01910, Plk-1 inhibitor",,,,,0.505,...+,699,46,46.0
tipifarnib-p1,ctrp_tipifarnib-P1,Not Clinically Relevant,,0.4,,0.4,,.+..,46,213,46.0
ml239,ctrp_ML239,Not Clinically Relevant,,0.397,,0.397,,.+..,48,214,48.0
semaxanib,cmap_semaxanib,"fusion protein analog of thrombopoietin, used to treat chronic immune thrombocytopenia",,,,,0.478,...+,700,49,49.0
unc1215,gdsc_UNC1215,Not Clinically Relevant,0.397,,,0.397,,+...,49,215,49.0
brd-a71883111,ctrp_BRD-A71883111,Not Clinically Relevant,,0.39399999999999996,,0.394,,.+..,50,216,50.0
palonosetron,cmap_palonosetron, 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting,,,,,0.474,...+,701,50,50.0
brd-m00053801,ctrp_BRD-M00053801,Not Clinically Relevant,,0.39299999999999996,,0.393,,.+..,51,217,51.0
16-beta-bromoandrosterone,ctrp_16-beta-bromoandrosterone,Not Clinically Relevant,,0.39299999999999996,,0.393,,.+..,52,218,52.0
navitoclax,ctrp_navitoclax,"Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and Bcl-w",0.711,0.335,,0.523,-0.091,++.-,11,93,52.0
xl765,ctrp_XL765,PI3K/mTOR inhibitor,,0.39,,0.39,,.+..,53,219,53.0
brd-k28456706,ctrp_BRD-K28456706,Not Clinically Relevant,,0.387,,0.387,,.+..,54,220,54.0
goserelin,cmap_goserelin,"decapeptide, synthetic analog of LHRH, suppresses production of testosterone and estrogen",,,,,0.444,...+,702,55,55.0
elcpk,ctrp_ELCPK,Not Clinically Relevant,,0.386,,0.386,,.+..,55,221,55.0
iu1,ctrp_IU1,Not Clinically Relevant,,0.385,,0.385,,.+..,56,222,56.0
streptozotocin,cmap_streptozotocin,"pancreatic beta cell toxin, used to treat metastatic cancer of pancreatic islet cells.",,,,,0.38299999999999995,...+,703,57,57.0
cil41,ctrp_CIL41,Not Clinically Relevant,,0.38299999999999995,,0.383,,.+..,58,223,58.0
tacrolimus,ctrp_tacrolimus,"FK-506, immunosuppressive drug usedafter allogeneic organ transplant",,0.379,,0.379,0.3945,.+.++-,61,56,58.5
cisplatin,gdsc_Cisplatin,Not Clinically Relevant,0.38,,,0.38,,+...,59,224,59.0
chlorambucil,ctrp_chlorambucil,"alkylates and cross-links DNA, interfering with DNA replication and damaging the DNA",,0.39899999999999997,,0.399,0.251,.+.+,47,71,59.0
vx-680,ctrp_VX-680,"VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C",,0.38,,0.38,,.+..,60,225,60.0
pirfenidone,cmap_pirfenidone, antifibrotic and anti-inflammatory,,,,,0.335,...+,704,62,62.0
ml203,ctrp_ML203,Not Clinically Relevant,,0.377,,0.377,,.+..,62,226,62.0
tegafur,cmap_tegafur,"antimetabolite, 5-fluorouracil analog, slowly metabolized to 5-FU",,,,,0.332,...+,705,63,63.0
compound 1541a,ctrp_Compound 1541A,Not Clinically Relevant,,0.377,,0.377,,.+..,63,227,63.0
epigallocatechin-3-monogallate,ctrp_epigallocatechin-3-monogallate,Not Clinically Relevant,,0.377,,0.377,,.+..,64,228,64.0
cs-1657,cmap_cs-1657,"Ixazomib, Proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome ",,,,,0.32799999999999996,...+,706,65,65.0
jw-74,ctrp_JW-74,Not Clinically Relevant,,0.376,,0.376,,.+..,66,229,66.0
brd-k11533227,ctrp_BRD-K11533227,Not Clinically Relevant,,0.375,,0.375,,.+..,67,230,67.0
mln-2238,cmap_mln-2238,"Ixazomib, Proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome ",,,,,0.281,...+,708,67,67.0
abt-199,ctrp_ABT-199,Bcl2 inhibitor,,0.374,,0.374,,.+..,68,231,68.0
methoxsalen,cmap_methoxsalen,used for skin diseases such as vitiligo and psoriasis,,,,,0.267,...+,709,69,69.0
bms-270394,ctrp_BMS-270394,Not Clinically Relevant,,0.374,,0.374,,.+..,69,232,69.0
foretinib,ctrp_foretinib,c-Met/VEGFR2 inhibitor,,0.373,,0.373,,.+..,70,233,70.0
aprepitant,cmap_aprepitant,"an antiemetic, mediates its effect by blocking the neurokinin 1 (NK1) receptor",,,,,0.264,...+,710,70,70.0
brd-k42260513,ctrp_BRD-K42260513,Not Clinically Relevant,,0.373,,0.373,,.+..,71,234,71.0
sz4ta2,ctrp_SZ4TA2,Not Clinically Relevant,,0.373,,0.373,,.+..,72,235,72.0
ac55649,ctrp_AC55649,Not Clinically Relevant,,0.37200000000000005,,0.372,,.+..,73,236,73.0
rg-108,ctrp_RG-108,Not Clinically Relevant,,0.371,,0.371,,.+..,74,237,74.0
brd-k29313308,ctrp_BRD-K29313308,Not Clinically Relevant,,0.369,,0.369,,.+..,75,238,75.0
itraconazole,ctrp_itraconazole,"Anti-fungal, hedgehog antagonist",,0.368,,0.368,0.165,.+.+,77,75,76.0
idarubicin,cmap_idarubicin,"Topo II inhibitor, intercalates into DNA, anthracycline",,,,,0.16250000000000003,...+-,677,76,76.0
sr1001,ctrp_SR1001,Not Clinically Relevant,,0.369,,0.369,,.+..,76,239,76.0
compound 1b,ctrp_compound 1B,Not Clinically Relevant,,0.368,,0.368,,.+..,78,240,78.0
brd-k29086754,ctrp_BRD-K29086754,Not Clinically Relevant,,0.368,,0.368,,.+..,79,241,79.0
floxuridine,cmap_floxuridine,"antimetabolite,  catabolized to 5-fluorouracil",,,,,0.15350000000000003,...+-,693,79,79.0
toremifene,cmap_toremifene,selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen,,,,,0.151,...+-,695,80,80.0
repligen 136,ctrp_Repligen 136,Not Clinically Relevant,,0.36700000000000005,,0.367,,.+..,81,242,81.0
cinacalcet,cmap_cinacalcet,Calcium reducer (increases  sensitivity of calcium receptors on parathyroid cells to reduce parathyroid hormone (PTH) levels and thus decrease serum calcium),,,,,0.125,...+,711,81,81.0
mst-312,ctrp_MST-312,Not Clinically Relevant,,0.36700000000000005,,0.367,,.+..,82,243,82.0
jw-55,ctrp_JW-55,Not Clinically Relevant,,0.36700000000000005,,0.367,,.+..,83,244,83.0
fingolimod,ctrp_fingolimod,"sphingosine-1-phosphate receptor modulator, sequesters lymphocytes in lymph nodes, mostly used for treating multiple sclerosis",,0.366,,0.366,,.+..,84,245,84.0
prednisone,cmap_prednisone,synthetic corticosteroid,,,,,0.085,...+,712,84,84.0
cytarabine hydrochloride,ctrp_cytarabine hydrochloride,Not Clinically Relevant,,0.366,,0.366,,.+..,85,246,85.0
nsc30930,ctrp_NSC30930,Not Clinically Relevant,,0.364,,0.364,,.+..,86,247,86.0
nilutamide,cmap_nilutamide," synthetic, non-steroidal antiandrogen, selective antagonist of the androgen receptor,  used for metastatic prostate cancer",,,,,0.07400000000000001,...+,713,86,86.0
qs-11,ctrp_QS-11,Not Clinically Relevant,,0.363,,0.363,,.+..,87,248,87.0
linsitinib,ctrp_linsitinib,IGF-1R inhibitor,0.6579999999999999,0.46799999999999997,,0.563,-0.907,++.-,8,166,87.0
cay10576,ctrp_CAY10576,Not Clinically Relevant,,0.363,,0.363,,.+..,88,249,88.0
rita,ctrp_RITA,Not Clinically Relevant,,0.36200000000000004,,0.362,,.+..,89,250,89.0
vorinostat,gdsc_Vorinostat,HDAC inhibitor (SAHA),0.32299999999999995,0.326,,0.324,0.919,++.+,167,12,89.5
brd-k84807411,ctrp_BRD-K84807411,Not Clinically Relevant,,0.36200000000000004,,0.362,,.+..,90,251,90.0
azd-6482,cmap_azd-6482,"PI3Kβ inhibitor, less active against PI3Kδ, PI3Kα and PI3Kγ ",,,,,-0.051,...-,714,90,90.0
brd-k92856060,ctrp_BRD-K92856060,Not Clinically Relevant,,0.36200000000000004,,0.362,,.+..,91,252,91.0
sildenafil,ctrp_sildenafil,"Viagra, used to treat erectile dysfunction and pulmonary arterial hypertension",,0.32799999999999996,,0.328,0.7570000000000001,.+.++,154,29,91.5
968,ctrp_968,Not Clinically Relevant,,0.36,,0.36,,.+..,92,253,92.0
necrostatin-7,ctrp_necrostatin-7,Not Clinically Relevant,,0.36,,0.36,,.+..,93,254,93.0
lenvatinib,ctrp_lenvatinib,"VEGFR inhibitor (VEGFR1, VEGFR2 and VEGFR3)",,0.359,,0.359,,.+..,94,255,94.0
anastrozole,cmap_anastrozole,"aromatase inhibitor, blocks conversion of androgens to estrogens",,,,,-0.1,...-,715,94,94.0
ml006,ctrp_ML006,Not Clinically Relevant,,0.358,,0.358,,.+..,95,256,95.0
ly-2183240,ctrp_LY-2183240,Not Clinically Relevant,,0.358,,0.358,,.+..,96,257,96.0
darinaparsin,ctrp_darinaparsin,organic arsenic compound composed of dimethylated arsenic linked to glutathione,,0.376,,0.376,-0.535,.+.-,65,127,96.0
kw-2449,ctrp_KW-2449,"multi-kinase inhibitor, mostly for Flt3, modestly potent to FGFR1, Bcr-Abl and Aurora A;",,0.35700000000000004,,0.357,,.+..,97,258,97.0
brd1835,ctrp_BRD1835,Not Clinically Relevant,,0.35700000000000004,,0.357,,.+..,98,259,98.0
myriocin,ctrp_myriocin,Not Clinically Relevant,,0.35700000000000004,,0.357,,.+..,99,260,99.0
ski-ii,ctrp_SKI-II,Not Clinically Relevant,,0.35600000000000004,,0.356,,.+..,100,261,100.0
nsc 74859,ctrp_NSC 74859,Not Clinically Relevant,,0.35600000000000004,,0.356,,.+..,101,262,101.0
brivanib,ctrp_brivanib,"multitargeted tyrosine kinase inhibitor, esp VEGFR and FGFR",,0.354,,0.354,-0.191,.+.-,105,98,101.5
npk76-ii-72-1,gdsc_NPK76-II-72-1,Not Clinically Relevant,0.35600000000000004,,,0.356,,+...,102,263,102.0
megestrol,cmap_megestrol,steroidal progestin used in the treatment of breast and endometrial cancer,,,,,-0.23424999999999999,...++-,691,103,103.0
brd-k75293299,ctrp_BRD-K75293299,Not Clinically Relevant,,0.355,,0.355,,.+..,103,264,103.0
aminoglutethimide,cmap_aminoglutethimide,"anti-steroid, used in the treatment of metastatic breast cancer",,,,,-0.25,...-,716,104,104.0
ml162,ctrp_ML162,Not Clinically Relevant,,0.354,,0.354,,.+..,104,265,104.0
daunorubicin,cmap_daunorubicin,"Analog of doxorubicin, DNA intercalator, Topo II antagonist",,,,,-0.27025,...+--,707,105,105.0
teniposide,ctrp_teniposide,Topo II inhibitor,,0.31,,0.31,0.893,.+.+,196,15,105.5
fgin-1-27,ctrp_FGIN-1-27,Not Clinically Relevant,,0.353,,0.353,,.+..,106,266,106.0
cyproterone,cmap_cyproterone,steroidal antiandrogen,,,,,-0.311,...-,718,107,107.0
brd-k34099515,ctrp_BRD-K34099515,Not Clinically Relevant,,0.35200000000000004,,0.352,,.+..,107,267,107.0
fsc231,ctrp_FSC231,Not Clinically Relevant,,0.35200000000000004,,0.352,,.+..,108,268,108.0
nsc48300,ctrp_NSC48300,Not Clinically Relevant,,0.35100000000000003,,0.351,,.+..,109,269,109.0
mgcd-265,ctrp_MGCD-265,"inhibitor of c-Met and VEGFR1/2/3, as well as Ron and Tie2",,0.35100000000000003,,0.351,,.+..,110,270,110.0
homoharringtonine,cmap_homoharringtonine,"natural product, protein translation inhibitor, used for myeloid leukemia",,,,,-0.324,...--,717,110,110.0
brd-k16147474,ctrp_BRD-K16147474,Not Clinically Relevant,,0.35,,0.35,,.+..,111,271,111.0
lomeguatrib,ctrp_lomeguatrib,"Inhibitor of MGMT, a DNA repair protein that confers resistance to alkylating agents such as Temozolomide, DTIC, Carmustine, etc. ",,0.349,,0.349,,.+..,112,272,112.0
mesna,cmap_mesna,used to decrease the risk of bleeding from the bladder after cyclophosphamide,,,,,-0.335,...-,719,112,112.0
plx4720,ccle_PLX4720,Not Clinically Relevant,,,0.349,0.349,,..+.,113,273,113.0
alfuzosin,cmap_alfuzosin,"alpha-blocker. Causes smooth muscles in the bladder neck and prostate to relax, whcih improves urine flow and reduces the symptoms of BPH.",,,,,-0.335,...-,720,113,113.0
ondansetron,cmap_ondansetron,"selective serotonin 5-HT3 receptor antagonist ,used to prevent nausea and vomiting caused by chemotherapy and radiotherapy",,,,,-0.35200000000000004,...-,721,114,114.0
mdivi-1,ctrp_Mdivi-1,Not Clinically Relevant,,0.348,,0.348,,.+..,114,274,114.0
belinostat,gdsc_Belinostat,HDAC inhibitor (PXD101),0.272,0.39399999999999996,,0.333,0.11599999999999999,++.+,147,82,114.5
bromfenac,cmap_bromfenac,"Nonsteroidal anti-Inflammatory drug, used to treat inflammation, esp in the eye",,,,,-0.358,...-,722,115,115.0
bms-754807,ctrp_BMS-754807,Not Clinically Relevant,0.34700000000000003,0.34700000000000003,,0.347,,++..,115,275,115.0
brd-k02251932,ctrp_BRD-K02251932,Not Clinically Relevant,,0.34600000000000003,,0.346,,.+..,116,276,116.0
fludarabine,cmap_fludarabine,"purine analog, inhibits DNA synthesis by interfering with ribonucleotide reductase and DNA polymerase.",,,,,-0.37099999999999994,...+--,682,117,117.0
ceranib-2,ctrp_ceranib-2,Not Clinically Relevant,,0.34600000000000003,,0.346,,.+..,117,277,117.0
tg-100-115,ctrp_TG-100-115,PI3Kγ/δ inhibitor,,0.345,,0.345,,.+..,118,278,118.0
cimetidine,ctrp_cimetidine,(Tagamet) Antacid and antihistamine,,0.33,,0.33,-0.009000000000000008,.+.+-,149,88,118.5
dactinomycin,cmap_dactinomycin,inhibits transcription by binding DNA at the transcription initiation complex and preventing elongation of RNA chain by RNA polymerase,,,,,-0.39649999999999996,...--,723,119,119.0
decitabine,ctrp_decitabine,"Nucleoside analog, inhibitor of DNA methylation and DNA synthesis (Dacogen)",,0.315,,0.315,0.485,.+.+,190,48,119.0
nvp-adw742,ctrp_NVP-ADW742,Not Clinically Relevant,,0.345,,0.345,,.+..,119,279,119.0
hydrocortisone,cmap_hydrocortisone,Anti-inflammatory,,,,,-0.399859375,...++++---,673,120,120.0
px-12,ctrp_PX-12,thioredoxin-1 (Trx-1) inhibitor,,0.344,,0.344,,.+..,120,280,120.0
cediranib,ctrp_cediranib,VEGFR inhibitor,,0.33299999999999996,,0.333,-0.132,.+.-,146,95,120.5
gsk-1059615,cmap_gsk-1059615,PI3Kα/β/δ/γ and mTOR inhibitor,,,,,-0.439,...-,724,121,121.0
brd8899,ctrp_BRD8899,Not Clinically Relevant,,0.34299999999999997,,0.343,,.+..,121,281,121.0
necrostatin-1,ctrp_necrostatin-1,Not Clinically Relevant,,0.34299999999999997,,0.343,,.+..,122,282,122.0
brd-k78574327,ctrp_BRD-K78574327,Not Clinically Relevant,,0.34299999999999997,,0.343,,.+..,123,283,123.0
everolimus,cmap_everolimus,mTOR inhibitor (RAD001),,,,,-0.503,...-,725,124,124.0
kpt185,ctrp_KPT185,Not Clinically Relevant,,0.342,,0.342,,.+..,124,284,124.0
elocalcitol,ctrp_elocalcitol,vitamin D receptor agonist,,0.342,,0.342,,.+..,125,285,125.0
azd-8055,cmap_azd-8055,mTOR inhibitor,,,,,-0.522,...-,726,125,125.0
hg-5-113-01,gdsc_HG-5-113-01,Not Clinically Relevant,0.342,,,0.342,,+...,126,286,126.0
pidorubicine,cmap_pidorubicine,"Analog of doxorubicin, DNA intercalator, Topo II antagonist",,,,,-0.534,...-,727,126,126.0
nsc23766,ctrp_NSC23766,Not Clinically Relevant,,0.342,,0.342,,.+..,127,287,127.0
pirarubicin,cmap_pirarubicin,"Analog of doxorubicin, DNA intercalator, Topo II antagonist",,,,,-0.55,...-,728,128,128.0
pdmp,ctrp_PDMP,Not Clinically Relevant,,0.341,,0.341,,.+..,128,288,128.0
bendamustine,ctrp_bendamustine,alkylating agent,,0.341,,0.341,,.+..,129,289,129.0
apicidin,ctrp_apicidin,Not Clinically Relevant,,0.341,,0.341,,.+..,130,290,130.0
jw-480,ctrp_JW-480,Not Clinically Relevant,,0.34,,0.34,,.+..,131,291,131.0
hyperforin,ctrp_hyperforin,"Active ingredient in St. John's Wort, blocks reuptake of of serotonin, norepinephrine, dopamine and GABA",,0.32799999999999996,,0.328,-0.315,.+.-,153,109,131.0
ubenimex,cmap_ubenimex,"inhibitor of the proinflammatory mediator, LTB4. Adjunct to chemotherapy for acute non-lymphocytic leukemia",,,,,-0.573,...-,729,132,132.0
brd6340,ctrp_BRD6340,Not Clinically Relevant,,0.33899999999999997,,0.339,,.+..,132,292,132.0
etoposide,gdsc_Etoposide,Topo II inhibitor,0.248,0.325,,0.286,0.9245000000000001,++.++,254,11,132.5
granisetron,cmap_granisetron,5-HT3 receptor antagonist used as an antiemetic,,,,,-0.575,...-,730,133,133.0
gmx-1778,ctrp_GMX-1778,Not Clinically Relevant,,0.33899999999999997,,0.339,,.+..,133,293,133.0
compound 23 citrate,ctrp_Compound 23 citrate,Not Clinically Relevant,,0.33899999999999997,,0.339,,.+..,134,294,134.0
tamibarotene,cmap_tamibarotene,"retinobenzoic acid, synthetic retinoid used to treat APL",,,,,-0.5770000000000001,...-,731,134,134.0
mitoxantrone,cmap_mitoxantrone,Topoisomerase II inhibitor; disrupts DNA synthesis and DNA repair ,,,,,-0.5820000000000001,...-,732,135,135.0
bibr-1532,ctrp_BIBR-1532,Not Clinically Relevant,,0.33899999999999997,,0.339,,.+..,135,295,135.0
azd-7762,cmap_azd-7762, Chk1 / Chk2 inhibitor,,,,,-0.591,...-,733,136,136.0
sgx-523,ctrp_SGX-523, Met inhibitor,,0.33899999999999997,,0.339,,.+..,136,296,136.0
plx-4032,ctrp_PLX-4032,BRAF (V600E) inhibitor,,0.336,,0.336,,.+..,137,297,137.0
lbw242,ccle_LBW242,Not Clinically Relevant,,,0.336,0.336,,..+.,138,298,138.0
ki8751,ctrp_Ki8751,Not Clinically Relevant,,0.335,,0.335,,.+..,139,299,139.0
omacetaxine mepesuccinate,ctrp_omacetaxine mepesuccinate,"natural product, protein translation inhibitor, used for myeloid leukemia",,0.335,,0.335,,.+..,140,300,140.0
brd-k66532283,ctrp_BRD-K66532283,Not Clinically Relevant,,0.335,,0.335,,.+..,141,301,141.0
ml083,ctrp_ML083,Not Clinically Relevant,,0.335,,0.335,,.+..,142,302,142.0
brd-k30019337,ctrp_BRD-K30019337,Not Clinically Relevant,,0.335,,0.335,,.+..,143,303,143.0
tofacitinib,cmap_tofacitinib,JAK Kinase inhibitor,,,,,-0.657,...-,734,144,144.0
erastin,ctrp_erastin,Not Clinically Relevant,,0.33399999999999996,,0.334,,.+..,144,304,144.0
cil70,ctrp_CIL70,Not Clinically Relevant,,0.33299999999999996,,0.333,,.+..,145,305,145.0
flutamide,cmap_flutamide,"nonsteroidal antiandrogen (NSAA), used primarily to treat prostate cancer",,,,,-0.665,...-,735,145,145.0
birb-796,ctrp_BIRB-796,Not Clinically Relevant,,0.332,,0.332,,.+..,148,306,148.0
propranolol,cmap_propranolol,"beta-blocker, used to treat high blood pressure, may have anti-cancer activity",,,,,-0.6970000000000001,...-,736,148,148.0
imiquimod,cmap_imiquimod,"immune response modifier, used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. ",,,,,-0.72,...-,737,149,149.0
isox,ctrp_ISOX,Not Clinically Relevant,,0.32899999999999996,,0.329,,.+..,150,307,150.0
sb-225002,ctrp_SB-225002,Not Clinically Relevant,,0.32899999999999996,,0.329,,.+..,151,308,151.0
tandutinib,ctrp_tandutinib,"FLT3 antagonist, also inhibits PDGFR and c-Kit, ",,0.32899999999999996,,0.329,-0.726,.+.-,152,150,151.0
niclosamide,ctrp_niclosamide,"used to treat tapeworm infestations,  inhibits glucose uptake, oxidative phosphorylation, and anaerobic metabolism in the tapeworm",,0.307,,0.307,-0.192,.+.-,206,100,153.0
letrozole,cmap_letrozole,"nonsteroidal aromatase inhibitor, prevents estrogen production, used for breast cancer",,,,,-0.7809999999999999,...-,738,154,154.0
thalidomide,ctrp_thalidomide,"interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma",,0.287,,0.287,0.35600000000000004,.+.+,249,60,154.5
brd-k37390332,ctrp_BRD-K37390332,Not Clinically Relevant,,0.327,,0.327,,.+..,155,309,155.0
etp-46464,ctrp_ETP-46464,Not Clinically Relevant,,0.327,,0.327,,.+..,156,310,156.0
ml031,ctrp_ML031,Not Clinically Relevant,,0.326,,0.326,,.+..,157,311,157.0
pifithrin-mu,ctrp_pifithrin-mu,Not Clinically Relevant,,0.326,,0.326,,.+..,158,312,158.0
ro4929097,ctrp_RO4929097,Notch (gamma secretase) inhibitor,,0.326,,0.326,,.+..,159,313,159.0
tacedinaline,ctrp_tacedinaline,Not Clinically Relevant,,0.326,,0.326,,.+..,160,314,160.0
hli 373,ctrp_HLI 373,Not Clinically Relevant,,0.326,,0.326,,.+..,161,315,161.0
mps-1-in-1,gdsc_MPS-1-IN-1,Not Clinically Relevant,0.325,,,0.325,,+...,162,316,162.0
isoevodiamine,ctrp_isoevodiamine,Not Clinically Relevant,,0.324,,0.324,,.+..,163,317,163.0
bix-01294,ctrp_BIX-01294,Not Clinically Relevant,,0.324,,0.324,,.+..,164,318,164.0
busulfan,cmap_busulfan,"alkylating agent, forms DNA-DNA intrastrand crosslinks, prevents DNA replication",,,,,-0.887,...-,739,164,164.0
gossypol,ctrp_gossypol,"Natural product, may function to inhibit Bcl2 family members",,0.28,,0.28,0.457,.+.+,276,53,164.5
riluzole,cmap_riluzole,"Blocks TTX-sensitive sodium channels, and kainate and NMDA glutamate receptors",,,,,-0.892,...-,740,165,165.0
at-406,ctrp_AT-406,Not Clinically Relevant,,0.324,,0.324,,.+..,165,319,165.0
brd-k04800985,ctrp_BRD-K04800985,Not Clinically Relevant,,0.324,,0.324,,.+..,166,320,166.0
daporinad,ctrp_daporinad,"inhibits biosynthesis of (NAD+ from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells",0.368,0.27699999999999997,,0.322,,++..,168,321,168.0
vincristine,ctrp_vincristine,"binds tubulin, disrupts microtubule dynamics",,0.293,,0.293,-0.20125,.+.+--,235,101,168.0
brd-k85133207,ctrp_BRD-K85133207,Not Clinically Relevant,,0.322,,0.322,,.+..,169,322,169.0
pyr-41,ctrp_PYR-41,Not Clinically Relevant,,0.322,,0.322,,.+..,170,323,170.0
sulindac,cmap_sulindac,Nonsteroidal anti-Inflammatory drug,,,,,-0.955,...-,741,170,170.0
brd-k80183349,ctrp_BRD-K80183349,Not Clinically Relevant,,0.322,,0.322,,.+..,171,324,171.0
clofarabine,ctrp_clofarabine,purine nucleoside antimetabolite,,0.265,,0.265,0.784,.+.+,318,25,171.5
zstk-474,cmap_zstk-474,"PI3K inhibitor, inhibits all four PI3K isoforms, but most active against PI3Kδ",,,,,-0.97,...-,742,172,172.0
brd-k44224150,ctrp_BRD-K44224150,Not Clinically Relevant,,0.322,,0.322,,.+..,172,325,172.0
pl-di,ctrp_PL-DI,Not Clinically Relevant,,0.322,,0.322,,.+..,173,326,173.0
metformin,cmap_metformin,Anti-diabetic AMPK Activator - mTOR Inhibitor - Autophagy inducer,,,,,-0.9840000000000001,...-,743,174,174.0
nsc95397,ctrp_NSC95397,Not Clinically Relevant,,0.321,,0.321,,.+..,174,327,174.0
ym201636,gdsc_YM201636,Not Clinically Relevant,0.321,,,0.321,,+...,175,328,175.0
lbh-589,ctrp_LBH-589,HDAC inhibitor,,0.321,,0.321,,.+..,176,329,176.0
nsc-207895,gdsc_NSC-207895,Not Clinically Relevant,0.32,,,0.32,,+...,177,330,177.0
cil55a,ctrp_CIL55A,Not Clinically Relevant,,0.32,,0.32,,.+..,178,331,178.0
neuronal differentiation inducer iii,ctrp_neuronal differentiation inducer III,Not Clinically Relevant,,0.32,,0.32,,.+..,179,332,179.0
nsc19630,ctrp_NSC19630,Not Clinically Relevant,,0.32,,0.32,,.+..,180,333,180.0
am-580,ctrp_AM-580,Not Clinically Relevant,,0.319,,0.319,,.+..,181,334,181.0
simvastatin,ctrp_simvastatin,"HMG-CoA reductase inhibitor,",,0.273,,0.273,0.32999999999999996,.+.++,299,64,181.5
tipifarnib-p2,ctrp_tipifarnib-P2,Not Clinically Relevant,,0.319,,0.319,,.+..,182,335,182.0
pf-184,ctrp_PF-184,Not Clinically Relevant,,0.319,,0.319,,.+..,183,336,183.0
alvocidib,ctrp_alvocidib,"Flavopiridol, CDK inhibitor, works against CDK1, 2, 4, 6 and 9",,0.295,,0.295,-0.594,.+.-,229,137,183.0
fluvastatin,ctrp_fluvastatin,"HMG-CoA reductase inhibitor,",,0.307,,0.307,-0.8759999999999999,.+.-,205,161,183.0
methotrexate,ctrp_methotrexate,"antimetabolite, competitively inhibits dihydrofolate reductase (DHFR), inhibits synthesis of DNA, RNA, thymidylates, and proteins",0.287,0.205,,0.246,0.873,++.+,348,18,183.0
triazolothiadiazine,ctrp_triazolothiadiazine,Not Clinically Relevant,,0.319,,0.319,,.+..,184,337,184.0
curcumin,ctrp_curcumin,"Natural Product, component of turmeric, may function as HDAC inhibitor",,0.281,,0.281,-0.184,.+.-,272,97,184.5
brd-k90370028,ctrp_BRD-K90370028,Not Clinically Relevant,,0.318,,0.318,,.+..,185,338,185.0
irinotecan,ccle_Irinotecan,"aka CPT-11, inhibitor of Topo I",,,0.23600000000000002,0.236,0.909,..++,357,14,185.5
azd4547,ctrp_AZD4547,"FGFR-1,2 and 3 inhibitor",,0.318,,0.318,,.+..,186,339,186.0
dacarbazine,ctrp_dacarbazine,"alkylating agent, Dacarbazine works by methylating guanine at the O-6 and N-7 positions",,0.317,,0.317,,.+..,187,340,187.0
fulvestrant,ctrp_fulvestrant,selective estrogen receptor degrader (SERD),,0.259,,0.259,0.5195,.+.++,331,44,187.5
hc-067047,ctrp_HC-067047,Not Clinically Relevant,,0.317,,0.317,,.+..,188,341,188.0
tg-101348,ctrp_TG-101348,JAK2 inhibitor,,0.243,,0.243,0.8109999999999999,.+.+,354,23,188.5
cucurbitacin i,ctrp_cucurbitacin I,Not Clinically Relevant,,0.315,,0.315,,.+..,189,342,189.0
mi-2,ctrp_MI-2,Not Clinically Relevant,,0.314,,0.314,,.+..,191,343,191.0
obatoclax,ctrp_obatoclax,Not Clinically Relevant,,0.25,,0.25,0.643,.+.+,344,39,191.5
brd-k02492147,ctrp_BRD-K02492147,Not Clinically Relevant,,0.314,,0.314,,.+..,192,344,192.0
qw-bi-011,ctrp_QW-BI-011,Not Clinically Relevant,,0.314,,0.314,,.+..,193,345,193.0
pifithrin-alpha,ctrp_pifithrin-alpha,Not Clinically Relevant,,0.313,,0.313,,.+..,194,346,194.0
lrrk2-in-1,ctrp_LRRK2-IN-1,Not Clinically Relevant,,0.313,,0.313,,.+..,195,347,195.0
parbendazole,ctrp_parbendazole,Not Clinically Relevant,,0.31,,0.31,,.+..,197,348,197.0
ciclopirox,ctrp_ciclopirox,antifungal agent for topical dermatologic treatment of superficial mycoses,,0.31,,0.31,,.+..,198,349,198.0
brd-k61166597,ctrp_BRD-K61166597,Not Clinically Relevant,,0.31,,0.31,,.+..,199,350,199.0
ku-0063794,ctrp_KU-0063794,Not Clinically Relevant,,0.309,,0.309,,.+..,200,351,200.0
brd-a94377914,ctrp_BRD-A94377914,Not Clinically Relevant,,0.308,,0.308,,.+..,201,352,201.0
serdemetan,gdsc_Serdemetan,"(JNJ-26854165) Mdm2 antagonist, stabilizes p53",-0.35,0.418,,0.034,0.769,-+.+,375,27,201.0
brd-k35604418,ctrp_BRD-K35604418,Not Clinically Relevant,,0.308,,0.308,,.+..,202,353,202.0
su11274,ctrp_SU11274,Not Clinically Relevant,,0.308,,0.308,,.+..,203,354,203.0
prochlorperazine,ctrp_prochlorperazine,"dopamine (D2) receptor antagonist, used for treatment of nausea and vertigo.",,0.276,,0.276,-0.368,.+.-,290,116,203.0
necrosulfonamide,ctrp_necrosulfonamide,Not Clinically Relevant,,0.307,,0.307,,.+..,204,355,204.0
temozolomide,gdsc_Temozolomide,alkylating agent,-0.395,0.29100000000000004,,-0.052,0.882,-+.+,393,17,205.0
gemcitabine,gdsc_Gemcitabine,"Nucleoside analog,incorporation into DNA creates an irreparable error that leads to inhibition of further DNA synthesis",-0.273,0.258,,-0.008,0.731,-+.+,380,32,206.0
cil56,ctrp_CIL56,Not Clinically Relevant,,0.306,,0.306,,.+..,207,356,207.0
sn-38,gdsc_SN-38,"Topo I inhibitor, active metabolite of irinotecan but 1000 times more active",-0.341,0.335,,-0.003,0.677,-+.+,379,35,207.0
entinostat,ctrp_entinostat,HDAC inhibitor,0.29,0.281,,0.286,-0.8809999999999999,++.-,252,163,207.5
azd1480,ctrp_AZD1480,JAK2 inhibitor with some activity against JAK3 and Tyk2,,0.304,,0.304,,.+..,208,357,208.0
zg-10,gdsc_ZG-10,Not Clinically Relevant,0.304,,,0.304,,+...,209,358,209.0
brd-k34222889,ctrp_BRD-K34222889,Not Clinically Relevant,,0.303,,0.303,,.+..,210,359,210.0
tgx-221,ctrp_TGX-221,Not Clinically Relevant,,0.302,,0.302,,.+..,211,360,211.0
brd-k41334119,ctrp_BRD-K41334119,Not Clinically Relevant,,0.302,,0.302,,.+..,212,361,212.0
dexamethasone,ctrp_dexamethasone,"synthetic corticosteroid, used to reduce inflammation",,0.23600000000000002,,0.236,0.28975000000000006,.+.++++++,358,66,212.0
ml311,ctrp_ML311,Not Clinically Relevant,,0.302,,0.302,,.+..,213,362,213.0
tamoxifen,gdsc_Tamoxifen,"ER antagonist prodrug; converted to 4-OHT and endoxifen in the liver; competes with estrogen for ER binding, inhibits transcription of estrogen target genes",-0.40700000000000003,0.34700000000000003,,-0.03,0.536,-+.+++,385,43,214.0
brd-k96431673,ctrp_BRD-K96431673,Not Clinically Relevant,,0.301,,0.301,,.+..,214,363,214.0
yk 4-279,ctrp_YK 4-279,Not Clinically Relevant,,0.301,,0.301,,.+..,215,364,215.0
pandacostat,ctrp_pandacostat,Not Clinically Relevant,,0.301,,0.301,,.+..,216,365,216.0
bi-2536,gdsc_BI-2536,"Plk1 inhibitor, less active against Plk2 and Plk3.",-0.316,0.276,,-0.02,0.462,-+.+,381,52,216.5
gsk-3 inhibitor ix,ctrp_GSK-3 inhibitor IX,Not Clinically Relevant,,0.3,,0.3,,.+..,217,366,217.0
zm447439,gdsc_ZM447439,Not Clinically Relevant,0.3,,,0.3,,+...,218,367,218.0
mitomycin,ctrp_mitomycin,"DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis",,0.299,,0.299,,.+..,219,368,219.0
manumycin a,ctrp_manumycin A,Not Clinically Relevant,,0.298,,0.298,,.+..,220,369,220.0
lovastatin,ctrp_lovastatin,"HMG-CoA reductase inhibitor,",,0.23,,0.23,0.154,.+.+,362,78,220.0
fqi-1,ctrp_FQI-1,Not Clinically Relevant,,0.298,,0.298,,.+..,221,370,221.0
vorapaxar,ctrp_vorapaxar," thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine",,0.298,,0.298,,.+..,222,371,222.0
cd-1530,ctrp_CD-1530,Not Clinically Relevant,,0.297,,0.297,,.+..,223,372,223.0
pitstop2,ctrp_pitstop2,Not Clinically Relevant,,0.297,,0.297,,.+..,224,373,224.0
mitomycin-c,gdsc_Mitomycin-C,"DNA Alkylator, works by cross-linking DNA and inhibiting DNA synthesis",0.23,,,0.23,0.08000000000000002,+..+-,363,85,224.0
tivozanib,gdsc_Tivozanib,VEGFR inhibitor,-0.546,0.32799999999999996,,-0.109,0.667,-+.+,412,37,224.5
brd1812,ctrp_BRD1812,Not Clinically Relevant,,0.297,,0.297,,.+..,225,374,225.0
osi-027,gdsc_OSI-027,Not Clinically Relevant,0.26,0.292,,0.276,-0.878,++.-,289,162,225.5
brd-k70511574,ctrp_BRD-K70511574,Not Clinically Relevant,,0.29600000000000004,,0.296,,.+..,226,375,226.0
tivantinib,ctrp_tivantinib,Met inhibitor,,0.29600000000000004,,0.296,,.+..,227,376,227.0
gdc-0941,ctrp_GDC-0941,"Pictilisib, potent inhibitor of PI3Kα/δ, with modest selectivity against p110β (11-fold) and p110γ",,0.275,,0.275,-0.855,.+.-,294,160,227.0
topotecan,ccle_Topotecan,Topo I inhibitor,,0.33399999999999996,0.205,0.269,-0.624,.++--,312,142,227.0
bms-345541,ctrp_BMS-345541,Not Clinically Relevant,0.34299999999999997,0.249,,0.296,,++..,228,377,228.0
importazole,ctrp_importazole,Not Clinically Relevant,,0.295,,0.295,,.+..,230,378,230.0
mk-1775,ctrp_MK-1775,Wee1 kinase inhibitor,,0.267,,0.267,-0.688,.+.-,314,147,230.5
stf-31,ctrp_STF-31,Not Clinically Relevant,,0.294,,0.294,,.+..,231,379,231.0
brd-k45681478,ctrp_BRD-K45681478,Not Clinically Relevant,,0.293,,0.293,,.+..,232,380,232.0
camptothecin,gdsc_Camptothecin,Not Clinically Relevant,0.293,,,0.293,,+...,233,381,233.0
sunitinib,gdsc_Sunitinib,"VEGFR2, PDGFRb and c-kit inhibitor; also inhibits FLT3",-0.418,0.304,,-0.057,0.218,-+.+-,395,73,234.0
sb-525334,ctrp_SB-525334,Not Clinically Relevant,,0.293,,0.293,,.+..,234,382,234.0
sorafenib,gdsc_Sorafenib,"VEGFR, PDGFR and Raf (c-Raf) inhibitor",-0.52,0.31,-0.242,-0.151,0.45499999999999996,-+-++,417,54,235.5
brd-k66453893,ctrp_BRD-K66453893,Not Clinically Relevant,,0.293,,0.293,,.+..,236,383,236.0
ouabain,ctrp_ouabain,Not Clinically Relevant,,0.293,,0.293,,.+..,237,384,237.0
tamatinib,ctrp_tamatinib,(R4060) inhibitor of IgE and IgG-mediated activation of Fc receptor signaling. Primary target is Syk,,0.292,,0.292,,.+..,238,385,238.0
doxorubicin,gdsc_Doxorubicin,"Topo II inhibitor, DNA intercalator",-0.271,0.28800000000000003,,0.009,-0.19199999999999995,-+.++-,377,99,238.0
ar-42,gdsc_AR-42,Not Clinically Relevant,0.292,,,0.292,,+...,239,386,239.0
nilotinib,ccle_Nilotinib,"inhibits the kinases BCR-ABL,[26] KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK",-0.217,0.33799999999999997,-0.32899999999999996,-0.069,0.154,-+-+,401,77,239.0
unc0638,ctrp_UNC0638,Not Clinically Relevant,0.293,0.29100000000000004,,0.292,,++..,240,387,240.0
pf2341066,ccle_PF2341066,"ALK, ROS1 and MET inhibitor",,,0.29100000000000004,0.291,,..+.,241,388,241.0
tretinoin,gdsc_Tretinoin,Retinoid,-0.623,0.413,,-0.105,0.22949999999999998,-+.++,410,72,241.0
merck60,ctrp_Merck60,Not Clinically Relevant,,0.29100000000000004,,0.291,,.+..,242,389,242.0
wz3105,gdsc_WZ3105,Not Clinically Relevant,0.29100000000000004,,,0.291,,+...,243,390,243.0
cytochalasin b,ctrp_cytochalasin B,Not Clinically Relevant,,0.29100000000000004,,0.291,,.+..,244,391,244.0
gsk2636771,ctrp_GSK2636771,"PI3K beta inhibitor, >900-fold selectivity over PI3Kα/PI3Kγ and >10-fold over PI3Kδ. ",,0.29,,0.29,,.+..,245,392,245.0
ym-155,ctrp_YM-155,"YM155 (Sepantronium Bromide), survivin suppressant ",,0.255,,0.255,-0.802,.+.-,336,155,245.5
sch-529074,ctrp_SCH-529074,Not Clinically Relevant,,0.29,,0.29,,.+..,246,393,246.0
cerulenin,ctrp_cerulenin,Not Clinically Relevant,,0.29,,0.29,,.+..,247,394,247.0
vinorelbine,gdsc_Vinorelbine,Not Clinically Relevant,-0.254,,,-0.254,0.3475,-..+++,434,61,247.5
byl-719,ctrp_BYL-719,PI3Kα inhibitor with minimal effect on PI3Kβ/γ/δ,,0.28800000000000003,,0.288,,.+..,248,395,248.0
docetaxel,gdsc_Docetaxel,inhibits microtubule dynamics; semi-synthetic analogue of paclitaxel,-0.361,0.259,,-0.051,-0.272,-+.+-,391,106,248.5
rigosertib,ctrp_rigosertib,"ON-01910, Plk-1 inhibitor",,0.287,,0.287,,.+..,250,396,250.0
paclitaxel,gdsc_Paclitaxel,disrupts microtubule dynamics,-0.355,0.254,-0.21600000000000003,-0.106,-0.07400000000000001,-+-+-,411,91,251.0
nintedanib,ctrp_nintedanib,"tyrosine-kinase inhibitor, targeting VEGFR, FGFR and PDGFR",,0.287,,0.287,,.+..,251,397,251.0
sirolimus,ctrp_sirolimus,"rapamycin, mTOR inhibitor",,0.22899999999999998,,0.229,-0.6131875,.+.+----,364,139,251.5
pha-793887,gdsc_PHA-793887,"CDK inhibitor, esp CDK2, CDK5 and CDK7",-0.324,0.275,,-0.024,-0.49200000000000005,-+.-,382,123,252.5
pi-103,gdsc_PI-103,Not Clinically Relevant,0.24600000000000002,0.325,,0.286,,++..,253,398,253.0
nvp-bez235,ctrp_NVP-BEZ235,PI3K/mTOR inhibitor,,0.255,,0.255,-0.9390000000000001,.+.-,338,168,253.0
brd-k27224038,ctrp_BRD-K27224038,Not Clinically Relevant,,0.28600000000000003,,0.286,,.+..,255,399,255.0
chm-1,ctrp_CHM-1,Not Clinically Relevant,,0.28600000000000003,,0.286,,.+..,256,400,256.0
bax channel blocker,ctrp_Bax channel blocker,Not Clinically Relevant,,0.28600000000000003,,0.286,,.+..,257,401,257.0
gw-843682x,ctrp_GW-843682X,Not Clinically Relevant,,0.28600000000000003,,0.286,,.+..,258,402,258.0
mk-2206,gdsc_MK-2206,Akt1/2/3 inhibitor,-0.366,0.303,,-0.032,-0.56,-+.-,386,131,258.5
blebbistatin,ctrp_blebbistatin,Not Clinically Relevant,,0.285,,0.285,,.+..,259,403,259.0
cal-101,ctrp_CAL-101,"Idelalisib,  PI3K/p110δ inhibitor",,0.285,,0.285,,.+..,260,404,260.0
marinopyrrole a,ctrp_marinopyrrole A,Not Clinically Relevant,,0.285,,0.285,,.+..,261,405,261.0
canertinib,ctrp_canertinib,"pan-ErbB inhibitor for EGFR and ErbB2,  no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4. ",,-0.298,,-0.298,0.6779999999999999,.-.+,490,34,262.0
smer-3,ctrp_SMER-3,Not Clinically Relevant,,0.284,,0.284,,.+..,262,406,262.0
imatinib,gdsc_Imatinib,"Bcr-abl, c-kit and PDGFR inhibitor",-0.26899999999999996,0.363,,0.047,-0.742,-+.-,374,151,262.5
fqi-2,ctrp_FQI-2,Not Clinically Relevant,,0.284,,0.284,,.+..,263,407,263.0
nsc632839,ctrp_NSC632839,Not Clinically Relevant,,0.284,,0.284,,.+..,264,408,264.0
masitinib,gdsc_Masitinib,"tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs",-0.436,0.243,,-0.096,-0.474,-+.-,407,122,264.5
ch-55,ctrp_Ch-55,Not Clinically Relevant,,0.284,,0.284,,.+..,265,409,265.0
cd-437,ctrp_CD-437,Not Clinically Relevant,,0.28300000000000003,,0.283,,.+..,266,410,266.0
gsk461364,ctrp_GSK461364,"Plk1 inhibitor, less active against Plk2 and Plk3.",,0.28300000000000003,,0.283,,.+..,267,411,267.0
kx2-391,ctrp_KX2-391,Src inhibitor (peptidomimetic) that targets the peptide substrate site of Src,,0.282,,0.282,,.+..,268,412,268.0
ml312,ctrp_ML312,Not Clinically Relevant,,0.282,,0.282,,.+..,269,413,269.0
aew541,ccle_AEW541,Not Clinically Relevant,,,0.282,0.282,,..+.,270,414,270.0
silmitasertib,ctrp_silmitasertib,casein kinase 2 inhibitor ,,0.281,,0.281,,.+..,271,415,271.0
neratinib,ctrp_neratinib,Her2 and EGFR inhibitor,,-0.289,,-0.289,0.275,.-.+,476,68,272.0
lapatinib,ctrp_lapatinib,HER2/EGFR inhibitor,-0.313,-0.331,-0.314,-0.319,0.7965,---++,521,24,272.5
panobinostat,ccle_Panobinostat,HDAC inhibitor,,,-0.304,-0.304,0.508,..-+,501,45,273.0
gsk1059615,ctrp_GSK1059615,PI3Kα/β/δ/γ and mTOR inhibitor,,0.281,,0.281,,.+..,273,416,273.0
crizotinib,gdsc_Crizotinib,"ALK, ROS1 and MET inhibitor",-0.596,0.318,,-0.139,-0.5539999999999999,-+.-,416,130,273.0
cay10618,ctrp_CAY10618,Not Clinically Relevant,,0.281,,0.281,,.+..,274,417,274.0
nakiterpiosin,ctrp_nakiterpiosin,Not Clinically Relevant,,0.281,,0.281,,.+..,275,418,275.0
agk-2,ctrp_AGK-2,Not Clinically Relevant,,0.28,,0.28,,.+..,277,419,277.0
i-bet151,ctrp_I-BET151,Not Clinically Relevant,,0.28,,0.28,,.+..,278,420,278.0
gant-61,ctrp_GANT-61,Not Clinically Relevant,,0.27899999999999997,,0.279,,.+..,279,421,279.0
prima-1,ctrp_PRIMA-1,Not Clinically Relevant,,0.278,,0.278,,.+..,280,422,280.0
temsirolimus,gdsc_Temsirolimus,Not Clinically Relevant,-0.415,0.26,,-0.077,-0.8109999999999999,-+.-,404,157,280.5
r428,ctrp_R428,Not Clinically Relevant,,0.278,,0.278,,.+..,281,423,281.0
momelotinib,ctrp_momelotinib,JAK1 and JAK2 inhibitor,,0.278,,0.278,,.+..,282,424,282.0
pazopanib,gdsc_Pazopanib,"KIT, FGFR, PDGFR and VEGFR inhibitor",-0.509,0.318,,-0.096,-0.835,-+.-,408,158,283.0
cr-1-31b,ctrp_CR-1-31B,Not Clinically Relevant,,0.278,,0.278,,.+..,283,425,283.0
5-fluorouracil,gdsc_5-Fluorouracil,antimetabolite,0.278,,,0.278,,+...,284,426,284.0
valdecoxib,ctrp_valdecoxib,"NSAID used in the treatment of osteoarthritis, rheumatoid arthritis",,-0.257,,-0.257,-0.5529999999999999,.-.-,440,129,284.5
mk-0752,ctrp_MK-0752,Notch (gamma secretase) inhibitor,,0.27699999999999997,,0.277,,.+..,285,427,285.0
cay10603,gdsc_CAY10603,Not Clinically Relevant,0.27699999999999997,,,0.277,,+...,286,428,286.0
b02,ctrp_B02,Not Clinically Relevant,,0.27699999999999997,,0.277,,.+..,287,429,287.0
bleomycin a2,ctrp_bleomycin A2,"Induces DNA strand breaks, inhibits incorporation of thymidine into DNA strands.",,0.276,,0.276,,.+..,288,430,288.0
triptolide,ctrp_triptolide,"diterpenoid epoxide from thunder god vine, may act on the XBP helicase that is a part of the TFIIH transcription factor complex",,-0.298,,-0.298,-0.01200000000000001,.-.+-,489,89,289.0
phenformin,gdsc_Phenformin,Anti-diabetic AMPK Activator - mTOR Inhibitor - Autophagy inducer,-0.255,,,-0.255,-0.623,-..-,437,141,289.0
vinblastine,gdsc_Vinblastine,"disrupts microtubule dynamics; vinca alkaloid, chemical analogue of vincristine",-0.3,,,-0.3,0.04200000000000001,-..+-,493,87,290.0
nvp-231,ctrp_NVP-231,Not Clinically Relevant,,0.276,,0.276,,.+..,291,431,291.0
jq-1,ctrp_JQ-1,Not Clinically Relevant,,0.276,,0.276,,.+..,292,432,292.0
srt-1720,ctrp_SRT-1720,Not Clinically Relevant,,0.275,,0.275,,.+..,293,433,293.0
salermide,ctrp_salermide,Not Clinically Relevant,,0.27399999999999997,,0.274,,.+..,295,434,295.0
methylstat,ctrp_methylstat,Not Clinically Relevant,,0.27399999999999997,,0.274,,.+..,296,435,296.0
quizartinib,gdsc_Quizartinib,Flt3 inhibitor,-0.705,0.285,,-0.21,-0.983,-+.-,420,173,296.5
tigecycline,ctrp_tigecycline,antibiotic used to treat a number of bacterial infections,,0.27399999999999997,,0.274,,.+..,297,436,297.0
narciclasine,ctrp_narciclasine,Not Clinically Relevant,,0.27399999999999997,,0.274,,.+..,298,437,298.0
ql-x-138,gdsc_QL-X-138,Not Clinically Relevant,0.273,,,0.273,,+...,300,438,300.0
gsk690693,gdsc_GSK690693,Not Clinically Relevant,0.273,,,0.273,,+...,301,439,301.0
cx-5461,gdsc_CX-5461,Not Clinically Relevant,0.273,,,0.273,,+...,302,440,302.0
pf-3758309,ctrp_PF-3758309,Not Clinically Relevant,,0.272,,0.272,,.+..,303,441,303.0
leptomycin b,ctrp_leptomycin B,Not Clinically Relevant,,0.272,,0.272,,.+..,304,442,304.0
cytarabine,gdsc_Cytarabine,"antimetabolite, causes DNA damage,  inhibits both DNA and RNA polymerases and nucleotide reductase enzymes needed for DNA synthesis",-0.34700000000000003,,,-0.347,0.47200000000000003,-..+,558,51,304.5
regorafenib,ctrp_regorafenib,VEGFR2-TIE2 inhibitor ,,0.272,,0.272,,.+..,305,443,305.0
purmorphamine,ctrp_purmorphamine,Not Clinically Relevant,,0.271,,0.271,,.+..,306,444,306.0
kh-cb19,ctrp_KH-CB19,Not Clinically Relevant,,0.27,,0.27,,.+..,307,445,307.0
lenalidomide,cmap_lenalidomide,"derivative of thalidomide, which interacts with the ubiquitin E3 ligase cereblon, targeting this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. Used for multiple myeloma",-0.413,,,-0.413,0.9890000000000001,-..+,613,1,307.0
ml210,ctrp_ML210,Not Clinically Relevant,,0.27,,0.27,,.+..,308,446,308.0
ex-527,ctrp_EX-527,SIRT1 inhibitor,,0.27,,0.27,,.+..,309,447,309.0
bardoxolone methyl,ctrp_bardoxolone methyl,Not Clinically Relevant,,0.27,,0.27,,.+..,310,448,310.0
prl-3 inhibitor i,ctrp_PRL-3 inhibitor I,Not Clinically Relevant,,0.26899999999999996,,0.269,,.+..,311,449,311.0
cudc-101,gdsc_CUDC-101,Not Clinically Relevant,0.26899999999999996,,,0.269,,+...,313,450,313.0
gsk525762a,ctrp_GSK525762A,Not Clinically Relevant,,0.267,,0.267,,.+..,315,451,315.0
abiraterone,ctrp_abiraterone,steroidal CYP17A1 inhibitor and androgen synthesis inhibitor ,,-0.33899999999999997,,-0.339,0.11199999999999999,.-.+,547,83,315.0
hbx-41108,ctrp_HBX-41108,Not Clinically Relevant,,0.265,,0.265,,.+..,316,452,316.0
az-3146,ctrp_AZ-3146,Not Clinically Relevant,,0.265,,0.265,,.+..,317,453,317.0
palbociclib,gdsc_Palbociclib,CDK4/6 inhibitor,-0.337,,,-0.337,-0.087,-..-,543,92,317.5
nvp-bsk805,ctrp_NVP-BSK805,Not Clinically Relevant,,0.264,,0.264,,.+..,319,454,319.0
wiki4,gdsc_WIKI4,Not Clinically Relevant,0.264,,,0.264,,+...,320,455,320.0
semagacestat,ctrp_semagacestat,Notch (gamma secretase) inhibitor,,0.263,,0.263,,.+..,321,456,321.0
unc0321,ctrp_UNC0321,Not Clinically Relevant,,0.263,,0.263,,.+..,322,457,322.0
cay10594,ctrp_CAY10594,Not Clinically Relevant,,0.263,,0.263,,.+..,323,458,323.0
neopeltolide,ctrp_neopeltolide,Not Clinically Relevant,,0.262,,0.262,,.+..,324,459,324.0
dinaciclib,ctrp_dinaciclib,"CDK inhibitor, esp CDK1, 2, 5, and 9",,0.262,,0.262,,.+..,325,460,325.0
procarbazine,ctrp_procarbazine,alkylating agent,,-0.344,,-0.344,-0.182,.-.-,554,96,325.0
brd9876,ctrp_BRD9876,Not Clinically Relevant,,0.262,,0.262,,.+..,326,461,326.0
trifluoperazine,ctrp_trifluoperazine,"antipsychotic, antiadrenergic and antidopaminergic. Blocks dopamine D1 and D2 receptors ",,-0.33799999999999997,,-0.338,-0.311,.-.-,545,108,326.5
at7867,ctrp_AT7867,Not Clinically Relevant,,0.262,,0.262,,.+..,327,462,327.0
azacitidine,ctrp_azacitidine,"Nucleoside analog, inhibitor of DNA methylation and DNA/RNA synthesis (Vidaza)",,-0.316,,-0.316,-0.603,.-.-,516,138,327.0
brd-k14844214,ctrp_BRD-K14844214,Not Clinically Relevant,,0.261,,0.261,,.+..,328,463,328.0
wz4002,ctrp_WZ4002,Not Clinically Relevant,,0.261,,0.261,,.+..,329,464,329.0
sb-743921,ctrp_SB-743921,kinesin spindle protein (KSP) inhibitor,,0.26,,0.26,,.+..,330,465,330.0
erismodegib,ctrp_erismodegib,Hedgehog (Smoothened) antagonist (LDE225),,-0.299,,-0.299,-0.943,.-.-,491,169,330.0
saracatinib,gdsc_Saracatinib,"kinase inhibitor, with selectivity against Src and Bcr-Abl",-0.34600000000000003,-0.27399999999999997,,-0.31,-0.769,--.-,509,152,330.5
3-cl-ahpc,ctrp_3-Cl-AHPC,Not Clinically Relevant,,0.257,,0.257,,.+..,332,466,332.0
sch-79797,ctrp_SCH-79797,Not Clinically Relevant,,0.257,,0.257,,.+..,333,467,333.0
gefitinib,gdsc_Gefitinib,EGFR inhibitor (Iressa),-0.517,-0.287,,-0.402,0.369,--.+,609,58,333.5
phloretin,ctrp_phloretin,Not Clinically Relevant,,0.256,,0.256,,.+..,334,468,334.0
selumetinib,gdsc_Selumetinib,MEK1 inhibitor,-0.537,-0.272,,-0.404,0.36200000000000004,--.+,610,59,334.5
pf-573228,ctrp_PF-573228,Not Clinically Relevant,,0.256,,0.256,,.+..,335,469,335.0
brd-a86708339,ctrp_BRD-A86708339,Not Clinically Relevant,,0.255,,0.255,,.+..,337,470,337.0
mln2480,ctrp_MLN2480,"TAK-580, pan-Raf kinase inhibitor",,0.255,,0.255,,.+..,339,471,339.0
tki258,ccle_TKI258,Not Clinically Relevant,,,0.252,0.252,,..+.,340,472,340.0
tw-37,ctrp_TW-37,Not Clinically Relevant,,0.251,,0.251,,.+..,341,473,341.0
sr-ii-138a,ctrp_SR-II-138A,Not Clinically Relevant,,0.251,,0.251,,.+..,342,474,342.0
genentech cpd 10,gdsc_Genentech Cpd 10,Not Clinically Relevant,0.25,,,0.25,,+...,343,475,343.0
bicalutamide,gdsc_Bicalutamide,"antiandrogen, used to treat prostate cancer",-0.374,,,-0.374,-0.203,-..-,586,102,344.0
ql-xii-47,gdsc_QL-XII-47,Not Clinically Relevant,0.248,,,0.248,,+...,345,476,345.0
cyclophosphamide,ctrp_cyclophosphamide,"alkylating agent, nitrogen mustard family, works by disrupting the duplication of DNA and the creation of RNA (Cytoxan)",,-0.33299999999999996,,-0.333,-0.8029999999999999,.-.-,534,156,345.0
"1s,3r-rsl-3","ctrp_1S,3R-RSL-3",Not Clinically Relevant,,0.24600000000000002,,0.246,,.+..,346,477,346.0
brd-k94991378,ctrp_BRD-K94991378,Not Clinically Relevant,,0.24600000000000002,,0.246,,.+..,347,478,347.0
ci-976,ctrp_CI-976,Not Clinically Relevant,,0.245,,0.245,,.+..,349,479,349.0
ml320,ctrp_ML320,Not Clinically Relevant,,0.245,,0.245,,.+..,350,480,350.0
pf-750,ctrp_PF-750,Not Clinically Relevant,,0.245,,0.245,,.+..,351,481,351.0
oligomycin a,ctrp_oligomycin A,Not Clinically Relevant,,0.244,,0.244,,.+..,352,482,352.0
tae684,ccle_TAE684,Not Clinically Relevant,,,0.244,0.244,,..+.,353,483,353.0
gw-405833,ctrp_GW-405833,Not Clinically Relevant,,0.243,,0.243,,.+..,355,484,355.0
veliparib,gdsc_Veliparib,PARP inhibitor.,-0.413,-0.262,,-0.338,-0.93,--.-,544,167,355.5
brd-a02303741,ctrp_BRD-A02303741,Not Clinically Relevant,,0.242,,0.242,,.+..,356,485,356.0
erlotinib,ctrp_erlotinib,EGFR inhibitor (Tarceva),-0.32299999999999995,-0.384,-0.326,-0.344,-0.848,----,553,159,356.0
dasatinib,gdsc_Dasatinib,"BCR-Abl, Src, c-Kit inhibitor",-0.406,-0.324,,-0.365,-0.622,--.-,577,140,358.5
brd-k01737880,ctrp_BRD-K01737880,Not Clinically Relevant,,0.233,,0.233,,.+..,359,486,359.0
le-135,ctrp_LE-135,Not Clinically Relevant,,0.233,,0.233,,.+..,360,487,360.0
etomoxir,ctrp_etomoxir,"agonist of PPARα, inhibitor of carnitine palmitoyltransferase-1 (CPT-1)",,-0.36700000000000005,,-0.367,-0.643,.-.--,579,143,361.0
dbeq,ctrp_DBeQ,Not Clinically Relevant,,0.231,,0.231,,.+..,361,488,361.0
wp1130,ctrp_WP1130,Not Clinically Relevant,,0.22699999999999998,,0.227,,.+..,365,489,365.0
myricetin,ctrp_myricetin,Not Clinically Relevant,,0.225,,0.225,,.+..,366,490,366.0
palmostatin b,ctrp_palmostatin B,Not Clinically Relevant,,0.223,,0.223,,.+..,367,491,367.0
brd4132,ctrp_BRD4132,Not Clinically Relevant,,0.222,,0.222,,.+..,368,492,368.0
ku 0060648,ctrp_KU 0060648,Not Clinically Relevant,,0.214,,0.214,,.+..,369,493,369.0
sid 26681509,ctrp_SID 26681509,Not Clinically Relevant,,0.213,,0.213,,.+..,370,494,370.0
thz-2-102-1,gdsc_THZ-2-102-1,Not Clinically Relevant,0.21100000000000002,,,0.211,,+...,371,495,371.0
gsk-j4,ctrp_GSK-J4,Not Clinically Relevant,,0.19399999999999998,,0.194,,.+..,372,496,372.0
brd-k30748066,ctrp_BRD-K30748066,Not Clinically Relevant,,0.19,,0.19,,.+..,373,497,373.0
afatinib,gdsc_Afatinib,EGFR and ErbB2 inhibitor,-0.5670000000000001,-0.349,,-0.458,-0.335,--.-,640,111,375.5
raf265,ccle_RAF265,inhibitor of C-Raf/B-Raf/B-Raf V600E,,0.26899999999999996,-0.204,0.032,,.+-.,376,498,376.0
nutlin-3,ccle_Nutlin-3,"Mdm2 antagonist, stabilizes p53 ",,0.301,-0.289,0.006,,.+-.,378,499,378.0
bosutinib,gdsc_Bosutinib,"BCR-Abl, Src, Lyn and Hck inhibitor",-0.541,-0.247,,-0.394,-0.774,--.-,604,153,378.5
tozasertib,gdsc_Tozasertib,"VX-680, pan-Aurora inhibitor, mostly against Aurora A, less potent towards Aurora B/C",-0.488,,,-0.488,-0.388,-..--,648,118,383.0
azd7762,gdsc_AZD7762, Chk1 / Chk2 inhibitor,-0.318,0.263,,-0.027,,-+..,383,500,383.0
pik-93,gdsc_PIK-93,Not Clinically Relevant,-0.332,0.275,,-0.028,,-+..,384,501,384.0
zstk474,gdsc_ZSTK474,"PI3K inhibitor, inhibits all four PI3K isoforms, but most active against PI3Kδ",-0.344,0.271,,-0.036,,-+..,387,502,387.0
osi-930,gdsc_OSI-930," inhibitor of Kit, KDR and CSF-1R; also potent to Flt-1, c-Raf and Lck",-0.379,0.303,,-0.038,,-+..,388,503,388.0
cabozantinib,gdsc_Cabozantinib,"MET, AXL, VEGFR and RET inhibitor",-0.41100000000000003,0.314,,-0.049,,-+..,389,504,389.0
dabrafenib,gdsc_Dabrafenib,Braf (V600E) inhibitor,-0.551,0.45,,-0.051,,-+..,390,505,390.0
mg-132,gdsc_MG-132,Not Clinically Relevant,-0.39799999999999996,0.293,,-0.052,,-+..,392,506,392.0
plx-4720,gdsc_PLX-4720,Not Clinically Relevant,-0.499,0.389,,-0.055,,-+..,394,507,394.0
azd8055,gdsc_AZD8055,mTOR inhibitor,-0.35,0.23600000000000002,,-0.057,,-+..,396,508,396.0
linifanib,gdsc_Linifanib,"RTK inhibitor, targets VEGFR, PDGFR, KDR, and CSF-1R",-0.5710000000000001,-0.284,,-0.428,-0.956,--.-,621,171,396.0
ku-55933,gdsc_KU-55933,Not Clinically Relevant,-0.445,0.331,,-0.057,,-+..,397,509,397.0
piperlongumine,gdsc_Piperlongumine,Not Clinically Relevant,-0.391,0.273,,-0.059,,-+..,398,510,398.0
bms-536924,gdsc_BMS-536924,Not Clinically Relevant,-0.415,0.287,,-0.064,,-+..,399,511,399.0
tpca-1,gdsc_TPCA-1,Not Clinically Relevant,-0.405,0.275,,-0.065,,-+..,400,512,400.0
ruxolitinib,gdsc_Ruxolitinib,"JAK1/2 inhibitor, used for myelofibrosis and polycythemia vera",-0.755,-0.33,,-0.542,-0.674,--.-,658,146,402.0
pevonedistat,gdsc_Pevonedistat,"(MLN4924), inhibitor of NEDD8-activating enzyme (NAE)",-0.384,0.23800000000000002,,-0.073,,-+..,402,513,402.0
nvp-tae684,gdsc_NVP-TAE684,Not Clinically Relevant,-0.45799999999999996,0.309,,-0.074,,-+..,403,514,403.0
chir-99021,gdsc_CHIR-99021,Not Clinically Relevant,-0.42200000000000004,0.257,,-0.083,,-+..,405,515,405.0
bexarotene,gdsc_Bexarotene,"retinoid that selectively activates retinoid X receptors (RXRs), induces cell differentiation and apoptosis ",-0.52,0.35100000000000003,,-0.084,,-+..,406,516,406.0
bortezomib,gdsc_Bortezomib,proteasome inhibitor (Velcade),-0.444,0.23399999999999999,,-0.105,,-+..,409,517,409.0
azd6482,gdsc_AZD6482,"PI3Kβ inhibitor, less active against PI3Kδ, PI3Kα and PI3Kγ ",-0.507,0.285,,-0.111,,-+..,413,518,413.0
parthenolide,gdsc_Parthenolide,Not Clinically Relevant,-0.522,0.26,,-0.131,,-+..,414,519,414.0
pac-1,gdsc_PAC-1,Not Clinically Relevant,-0.513,0.251,,-0.131,,-+..,415,520,415.0
brd-k71935468,ctrp_BRD-K71935468,Not Clinically Relevant,,-0.195,,-0.195,,.-..,418,521,418.0
brd-k33514849,ctrp_BRD-K33514849,Not Clinically Relevant,,-0.198,,-0.198,,.-..,419,522,419.0
stemregenin 1,ctrp_StemRegenin 1,Not Clinically Relevant,,-0.226,,-0.226,,.-..,421,523,421.0
sns-032,ctrp_SNS-032,"CDK inhibitor, esp CDK2 , 7 and 9 ",,-0.228,,-0.228,,.-..,422,524,422.0
vandetanib,ctrp_vandetanib,"VEGFR, EGFR and RET inhibitor",,-0.22899999999999998,,-0.229,,.-..,423,525,423.0
avicin d,ctrp_avicin D,Not Clinically Relevant,,-0.231,,-0.231,,.-..,424,526,424.0
azd0530,ccle_AZD0530,"kinase inhibitor, with selectivity against Src and Bcr-Abl",,,-0.233,-0.233,,..-.,425,527,425.0
sepantronium bromide,gdsc_Sepantronium bromide,"YM155 (Sepantronium Bromide), survivin suppressant ",-0.23800000000000002,,,-0.238,,-...,426,528,426.0
brd-k63431240,ctrp_BRD-K63431240,Not Clinically Relevant,,-0.24,,-0.24,,.-..,427,529,427.0
brd8958,ctrp_BRD8958,Not Clinically Relevant,,-0.242,,-0.242,,.-..,428,530,428.0
betulinic acid,ctrp_betulinic acid,Not Clinically Relevant,,-0.244,,-0.244,,.-..,429,531,429.0
dacinostat,gdsc_Dacinostat,Not Clinically Relevant,-0.244,,,-0.244,,-...,430,532,430.0
brd-k97651142,ctrp_BRD-K97651142,Not Clinically Relevant,,-0.244,,-0.244,,.-..,431,533,431.0
jw-7-24-1,gdsc_JW-7-24-1,Not Clinically Relevant,-0.254,,,-0.254,,-...,432,534,432.0
brefeldin a,ctrp_brefeldin A,Not Clinically Relevant,,-0.254,,-0.254,,.-..,433,535,433.0
zd-6474,ccle_ZD-6474,"VEGFR, EGFR and RET inhibitor",,,-0.254,-0.254,,..-.,435,536,435.0
mln2238,ctrp_MLN2238,"Ixazomib, Proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome ",,-0.255,,-0.255,,.-..,436,537,436.0
ipa-3,gdsc_IPA-3,Not Clinically Relevant,-0.256,,,-0.256,,-...,438,538,438.0
spautin-1,ctrp_spautin-1,Not Clinically Relevant,,-0.257,,-0.257,,.-..,439,539,439.0
bafilomycin a1,ctrp_bafilomycin A1,Not Clinically Relevant,,-0.259,,-0.259,,.-..,441,540,441.0
ver-155008,ctrp_VER-155008,Not Clinically Relevant,,-0.26,,-0.26,,.-..,442,541,442.0
sb590885,gdsc_SB590885,Not Clinically Relevant,-0.26,,,-0.26,,-...,443,542,443.0
khs101,ctrp_KHS101,Not Clinically Relevant,,-0.261,,-0.261,,.-..,444,543,444.0
sr8278,ctrp_SR8278,Not Clinically Relevant,,-0.261,,-0.261,,.-..,445,544,445.0
ciclosporin,ctrp_ciclosporin,,,-0.262,,-0.262,,.-..,446,545,446.0
jq1,gdsc_JQ1,Not Clinically Relevant,-0.264,,,-0.264,,-...,447,546,447.0
pd-0332991,ccle_PD-0332991,CDK4/6 inhibitor,,,-0.264,-0.264,,..-.,448,547,448.0
brd-k55116708,ctrp_BRD-K55116708,Not Clinically Relevant,,-0.266,,-0.266,,.-..,449,548,449.0
ng-25,gdsc_NG-25,Not Clinically Relevant,-0.266,,,-0.266,,-...,450,549,450.0
tw 37,gdsc_TW 37,Not Clinically Relevant,-0.26899999999999996,,,-0.269,,-...,451,550,451.0
nelarabine,ctrp_nelarabine,"purine nucleoside analog, which causes inhibition of DNA synthesis and cytotoxicity",,-0.27,,-0.27,,.-..,452,551,452.0
tl-1-85,gdsc_TL-1-85,Not Clinically Relevant,-0.27,,,-0.27,,-...,453,552,453.0
brd-k48477130,ctrp_BRD-K48477130,Not Clinically Relevant,,-0.27,,-0.27,,.-..,454,553,454.0
pd-0325901,ccle_PD-0325901,Not Clinically Relevant,,,-0.271,-0.271,,..-.,455,554,455.0
epothilone b,gdsc_Epothilone B,Not Clinically Relevant,-0.271,,,-0.271,,-...,456,555,456.0
col-3,ctrp_COL-3,matrix metalloproteinase (MMP) inhibitor,,-0.273,,-0.273,,.-..,457,556,457.0
snx-2112,gdsc_SNX-2112,Not Clinically Relevant,-0.287,-0.262,,-0.274,,--..,458,557,458.0
pyrazolanthrone,ctrp_pyrazolanthrone,Not Clinically Relevant,,-0.27399999999999997,,-0.274,,.-..,459,558,459.0
brd-k09344309,ctrp_BRD-K09344309,Not Clinically Relevant,,-0.275,,-0.275,,.-..,460,559,460.0
brd-a05715709,ctrp_BRD-A05715709,Not Clinically Relevant,,-0.276,,-0.276,,.-..,461,560,461.0
ml258,ctrp_ML258,Not Clinically Relevant,,-0.27699999999999997,,-0.277,,.-..,462,561,462.0
fluorouracil,ctrp_fluorouracil,antimetabolite,,-0.27699999999999997,,-0.277,,.-..,463,562,463.0
dmog,gdsc_DMOG,Not Clinically Relevant,-0.27699999999999997,,,-0.277,,-...,464,563,464.0
wz8040,ctrp_WZ8040,Not Clinically Relevant,,-0.278,,-0.278,,.-..,465,564,465.0
cp466722,gdsc_CP466722,Not Clinically Relevant,-0.278,,,-0.278,,-...,466,565,466.0
ml334 diastereomer,ctrp_ML334 diastereomer,Not Clinically Relevant,,-0.281,,-0.281,,.-..,467,566,467.0
lestauritinib,gdsc_Lestauritinib,Not Clinically Relevant,-0.282,,,-0.282,,-...,468,567,468.0
at-7519,gdsc_AT-7519,Not Clinically Relevant,-0.282,,,-0.282,,-...,469,568,469.0
bec,ctrp_BEC,Not Clinically Relevant,,-0.282,,-0.282,,.-..,470,569,470.0
cid-5951923,ctrp_CID-5951923,Not Clinically Relevant,,-0.28300000000000003,,-0.283,,.-..,471,570,471.0
azd7545,ctrp_AZD7545,Not Clinically Relevant,,-0.285,,-0.285,,.-..,472,571,472.0
ko-143,ctrp_Ko-143,Not Clinically Relevant,,-0.285,,-0.285,,.-..,473,572,473.0
bay-61-3606,gdsc_BAY-61-3606,Not Clinically Relevant,-0.28800000000000003,,,-0.288,,-...,474,573,474.0
sj-172550,ctrp_SJ-172550,Not Clinically Relevant,,-0.289,,-0.289,,.-..,475,574,475.0
bcl-lzh-4,ctrp_BCL-LZH-4,Not Clinically Relevant,,-0.29,,-0.29,,.-..,477,575,477.0
17-aag,ccle_17-AAG,Not Clinically Relevant,,,-0.29100000000000004,-0.291,,..-.,478,576,478.0
pluripotin,ctrp_pluripotin,Not Clinically Relevant,,-0.292,,-0.292,,.-..,479,577,479.0
thz-2-49,gdsc_THZ-2-49,Not Clinically Relevant,-0.292,,,-0.292,,-...,480,578,480.0
tosedostat,ctrp_tosedostat,inhibitor of the M1 family of aminopeptidases,,-0.292,,-0.292,,.-..,481,579,481.0
gw843682x,gdsc_GW843682X,Not Clinically Relevant,-0.292,,,-0.292,,-...,482,580,482.0
bx796,gdsc_BX796,Not Clinically Relevant,-0.293,,,-0.293,,-...,483,581,483.0
ku-60019,ctrp_KU-60019,Not Clinically Relevant,,-0.294,,-0.294,,.-..,484,582,484.0
l-685458,ctrp_L-685458,Not Clinically Relevant,,-0.327,-0.263,-0.295,,.--.,485,583,485.0
fumonisin b1,ctrp_fumonisin B1,Not Clinically Relevant,,-0.29600000000000004,,-0.296,,.-..,486,584,486.0
cyanoquinoline 11,ctrp_cyanoquinoline 11,Not Clinically Relevant,,-0.29600000000000004,,-0.296,,.-..,487,585,487.0
n9-isopropylolomoucine,ctrp_N9-isopropylolomoucine,Not Clinically Relevant,,-0.297,,-0.297,,.-..,488,586,488.0
aa-cocf3,ctrp_AA-COCF3,Not Clinically Relevant,,-0.299,,-0.299,,.-..,492,587,492.0
brd-k64610608,ctrp_BRD-K64610608,Not Clinically Relevant,,-0.3,,-0.3,,.-..,494,588,494.0
way-362450,ctrp_WAY-362450,Not Clinically Relevant,,-0.301,,-0.301,,.-..,495,589,495.0
vaf-347,ctrp_VAF-347,Not Clinically Relevant,,-0.301,,-0.301,,.-..,496,590,496.0
brd-k17060750,ctrp_BRD-K17060750,Not Clinically Relevant,,-0.301,,-0.301,,.-..,497,591,497.0
austocystin d,ctrp_austocystin D,Not Clinically Relevant,,-0.302,,-0.302,,.-..,498,592,498.0
gsk650394,gdsc_GSK650394,Not Clinically Relevant,-0.303,,,-0.303,,-...,499,593,499.0
brd-k48334597,ctrp_BRD-K48334597,Not Clinically Relevant,,-0.303,,-0.303,,.-..,500,594,500.0
gsk4112,ctrp_GSK4112,Not Clinically Relevant,,-0.304,,-0.304,,.-..,502,595,502.0
npc-26,ctrp_NPC-26,Not Clinically Relevant,,-0.306,,-0.306,,.-..,503,596,503.0
osu-03012,gdsc_OSU-03012,Not Clinically Relevant,-0.307,,,-0.307,,-...,504,597,504.0
c6-ceramide,ctrp_C6-ceramide,Not Clinically Relevant,,-0.308,,-0.308,,.-..,505,598,505.0
at13387,ctrp_AT13387,Selective potent Hsp90 inhibitor,,-0.308,,-0.308,,.-..,506,599,506.0
ly-2157299,ctrp_LY-2157299,Not Clinically Relevant,,-0.308,,-0.308,,.-..,507,600,507.0
omipalisib,gdsc_Omipalisib,Not Clinically Relevant,-0.308,,,-0.308,,-...,508,601,508.0
pd318088,ctrp_PD318088,Not Clinically Relevant,,-0.31,,-0.31,,.-..,510,602,510.0
yk-4-279,gdsc_YK-4-279,Not Clinically Relevant,-0.312,,,-0.312,,-...,511,603,511.0
i-bet-762,gdsc_I-BET-762,Not Clinically Relevant,-0.314,,,-0.314,,-...,512,604,512.0
brd-k71781559,ctrp_BRD-K71781559,Not Clinically Relevant,,-0.314,,-0.314,,.-..,513,605,513.0
gdc-0879,ctrp_GDC-0879,Not Clinically Relevant,,-0.315,,-0.315,,.-..,514,606,514.0
jq12,gdsc_JQ12,Not Clinically Relevant,-0.315,,,-0.315,,-...,515,607,515.0
ml029,ctrp_ML029,Not Clinically Relevant,,-0.317,,-0.317,,.-..,517,608,517.0
thapsigargin,gdsc_Thapsigargin,Not Clinically Relevant,-0.317,,,-0.317,,-...,518,609,518.0
pf-543,ctrp_PF-543,Not Clinically Relevant,,-0.317,,-0.317,,.-..,519,610,519.0
shikonin,gdsc_Shikonin,Not Clinically Relevant,-0.318,,,-0.318,,-...,520,611,520.0
brd-k33199242,ctrp_BRD-K33199242,Not Clinically Relevant,,-0.32,,-0.32,,.-..,522,612,522.0
pfi-1,gdsc_PFI-1,Not Clinically Relevant,-0.321,,,-0.321,,-...,523,613,523.0
elesclomol,gdsc_Elesclomol,Not Clinically Relevant,-0.321,,,-0.321,,-...,524,614,524.0
istradefylline,ctrp_istradefylline,"adenosine A2A receptor antagonist, useful in the treatment of Parkinson's disease",,-0.322,,-0.322,,.-..,525,615,525.0
seliciclib,gdsc_Seliciclib,Not Clinically Relevant,-0.324,,,-0.324,,-...,526,616,526.0
vu0155056,ctrp_VU0155056,Not Clinically Relevant,,-0.326,,-0.326,,.-..,527,617,527.0
brd-k41597374,ctrp_BRD-K41597374,Not Clinically Relevant,,-0.326,,-0.326,,.-..,528,618,528.0
azd6244,ccle_AZD6244,MEK1 inhibitor,,,-0.32799999999999996,-0.328,,..-.,529,619,529.0
ifosfamide,ctrp_ifosfamide,"alkylating agent, nitrogen mustard family, works by disrupting the duplication of DNA and the creation of RNA",,-0.32899999999999996,,-0.329,,.-..,530,620,530.0
ponatinib,gdsc_Ponatinib,Bcr-abl inhibitor,-0.32899999999999996,,,-0.329,,-...,531,621,531.0
a-804598,ctrp_A-804598,Not Clinically Relevant,,-0.33299999999999996,,-0.333,,.-..,532,622,532.0
xmd8-92,gdsc_XMD8-92,Not Clinically Relevant,-0.33299999999999996,,,-0.333,,-...,533,623,533.0
ic-87114,ctrp_IC-87114,Not Clinically Relevant,,-0.33299999999999996,,-0.333,,.-..,535,624,535.0
a-443654,gdsc_A-443654,Not Clinically Relevant,-0.33299999999999996,,,-0.333,,-...,536,625,536.0
trametinib,gdsc_Trametinib,MEK inhibitor (MEK1 and MEK2),-0.38,-0.28600000000000003,,-0.333,,--..,537,626,537.0
as605240,gdsc_AS605240,Not Clinically Relevant,-0.33399999999999996,,,-0.334,,-...,538,627,538.0
fedratinib,gdsc_Fedratinib,JAK2 inhibitor,-0.33399999999999996,,,-0.334,,-...,539,628,539.0
kin001-244,gdsc_KIN001-244,Not Clinically Relevant,-0.335,,,-0.335,,-...,540,629,540.0
cct-018159,gdsc_CCT-018159,Not Clinically Relevant,-0.336,,,-0.336,,-...,541,630,541.0
sgc0946,gdsc_SGC0946,Not Clinically Relevant,-0.336,,,-0.336,,-...,542,631,542.0
embelin,gdsc_Embelin,Not Clinically Relevant,-0.33899999999999997,,,-0.339,,-...,546,632,546.0
pictilisib,gdsc_Pictilisib,"Pictilisib, potent inhibitor of PI3Kα/δ, with modest selectivity against p110β (11-fold) and p110γ",-0.34,,,-0.34,,-...,548,633,548.0
pf-562271,gdsc_PF-562271,Not Clinically Relevant,-0.341,,,-0.341,,-...,549,634,549.0
brd-k50799972,ctrp_BRD-K50799972,Not Clinically Relevant,,-0.342,,-0.342,,.-..,550,635,550.0
s-trityl-l-cysteine,gdsc_S-Trityl-L-cysteine,Not Clinically Relevant,-0.34299999999999997,,,-0.343,,-...,551,636,551.0
brd-k96970199,ctrp_BRD-K96970199,Not Clinically Relevant,,-0.34299999999999997,,-0.343,,.-..,552,637,552.0
mi-1,ctrp_MI-1,Not Clinically Relevant,,-0.344,,-0.344,,.-..,555,638,555.0
brd9647,ctrp_BRD9647,Not Clinically Relevant,,-0.34700000000000003,,-0.347,,.-..,556,639,556.0
luminespib,gdsc_Luminespib,Not Clinically Relevant,-0.34700000000000003,,,-0.347,,-...,557,640,557.0
brd-k09587429,ctrp_BRD-K09587429,Not Clinically Relevant,,-0.348,,-0.348,,.-..,559,641,559.0
pd0325901,gdsc_PD0325901,Not Clinically Relevant,-0.348,,,-0.348,,-...,560,642,560.0
zibotentan,gdsc_Zibotentan,Not Clinically Relevant,-0.349,,,-0.349,,-...,561,643,561.0
cbb-1007,ctrp_CBB-1007,Not Clinically Relevant,,-0.35100000000000003,,-0.351,,.-..,562,644,562.0
brd-k86535717,ctrp_BRD-K86535717,Not Clinically Relevant,,-0.35100000000000003,,-0.351,,.-..,563,645,563.0
pyrimethamine,gdsc_Pyrimethamine,Not Clinically Relevant,-0.35100000000000003,,,-0.351,,-...,564,646,564.0
bleomycin,gdsc_Bleomycin,"Induces DNA strand breaks, inhibits incorporation of thymidine into DNA strands.",-0.35200000000000004,,,-0.352,,-...,565,647,565.0
isonicotinohydroxamic acid,ctrp_isonicotinohydroxamic acid,Not Clinically Relevant,,-0.35200000000000004,,-0.352,,.-..,566,648,566.0
brd-k19103580,ctrp_BRD-K19103580,Not Clinically Relevant,,-0.35200000000000004,,-0.352,,.-..,567,649,567.0
midostaurin,gdsc_Midostaurin,Not Clinically Relevant,-0.35200000000000004,,,-0.352,,-...,568,650,568.0
ipr-456,ctrp_IPR-456,Not Clinically Relevant,,-0.355,,-0.355,,.-..,569,651,569.0
tipifarnib,gdsc_Tipifarnib,Not Clinically Relevant,-0.355,,,-0.355,,-...,570,652,570.0
brd-k27986637,ctrp_BRD-K27986637,Not Clinically Relevant,,-0.358,,-0.358,,.-..,571,653,571.0
gsk269962a,gdsc_GSK269962A,Not Clinically Relevant,-0.358,,,-0.358,,-...,572,654,572.0
cmk,gdsc_CMK,Not Clinically Relevant,-0.358,,,-0.358,,-...,573,655,573.0
aica ribonucleotide,gdsc_AICA Ribonucleotide,Not Clinically Relevant,-0.359,,,-0.359,,-...,574,656,574.0
ibrutinib,ctrp_ibrutinib,BTK kinase inhibitor,,-0.36200000000000004,,-0.362,,.-..,575,657,575.0
hg6-64-1,gdsc_HG6-64-1,Not Clinically Relevant,-0.36200000000000004,,,-0.362,,-...,576,658,576.0
bleomycin (50 um),gdsc_Bleomycin (50 uM),Not Clinically Relevant,-0.366,,,-0.366,,-...,578,659,578.0
wh-4-023,gdsc_WH-4-023,Not Clinically Relevant,-0.368,,,-0.368,,-...,580,660,580.0
salubrinal,gdsc_Salubrinal,Not Clinically Relevant,-0.369,,,-0.369,,-...,581,661,581.0
zebularine,ctrp_zebularine,Not Clinically Relevant,,-0.369,,-0.369,,.-..,582,662,582.0
jnk-9l,gdsc_JNK-9L,Not Clinically Relevant,-0.37,,,-0.37,,-...,583,663,583.0
akt inhibitor viii,gdsc_AKT inhibitor VIII,Not Clinically Relevant,-0.37,,,-0.37,,-...,584,664,584.0
obatoclax mesylate,gdsc_Obatoclax Mesylate,Not Clinically Relevant,-0.371,,,-0.371,,-...,585,665,585.0
lfm-a13,gdsc_LFM-A13,Not Clinically Relevant,-0.375,,,-0.375,,-...,587,666,587.0
birinapant,ctrp_birinapant,"SMAC mimetic, mostly to cIAP1, less potent against XIAP.",,-0.376,,-0.376,,.-..,588,667,588.0
brd-k52037352,ctrp_BRD-K52037352,Not Clinically Relevant,,-0.376,,-0.376,,.-..,589,668,589.0
pd 153035,ctrp_PD 153035,Not Clinically Relevant,,-0.377,,-0.377,,.-..,590,669,590.0
tgx221,gdsc_TGX221,Not Clinically Relevant,-0.379,,,-0.379,,-...,591,670,591.0
dactolisib,gdsc_Dactolisib,PI3K/mTOR inhibitor,-0.38,,,-0.38,,-...,592,671,592.0
enzastaurin,gdsc_Enzastaurin,Not Clinically Relevant,-0.38,,,-0.38,,-...,593,672,593.0
nvp-bhg712,gdsc_NVP-BHG712,Not Clinically Relevant,-0.381,,,-0.381,,-...,594,673,594.0
as601245,gdsc_AS601245,Not Clinically Relevant,-0.384,,,-0.384,,-...,595,674,595.0
refametinib,gdsc_Refametinib,Not Clinically Relevant,-0.385,,,-0.385,,-...,596,675,596.0
fh535,gdsc_FH535,Not Clinically Relevant,-0.385,,,-0.385,,-...,597,676,597.0
(5z)-7-oxozeaenol,gdsc_(5Z)-7-Oxozeaenol,Not Clinically Relevant,-0.386,,,-0.386,,-...,598,677,598.0
pf-4800567 hydrochloride,ctrp_PF-4800567 hydrochloride,Not Clinically Relevant,,-0.386,,-0.386,,.-..,599,678,599.0
ql-viii-58,gdsc_QL-VIII-58,Not Clinically Relevant,-0.38799999999999996,,,-0.388,,-...,600,679,600.0
tanespimycin,gdsc_Tanespimycin,HSP90 inhibitor,-0.48100000000000004,-0.299,,-0.39,,--..,601,680,601.0
sb-431542,ctrp_SB-431542,Not Clinically Relevant,,-0.392,,-0.392,,.-..,602,681,602.0
xmd11-85h,gdsc_XMD11-85h,Not Clinically Relevant,-0.39299999999999996,,,-0.393,,-...,603,682,603.0
kin001-266,gdsc_KIN001-266,Not Clinically Relevant,-0.396,,,-0.396,,-...,605,683,605.0
o-6-benzylguanine,ctrp_O-6-benzylguanine,"guanine analog, binds the DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) resulting in inhibition of AGT-mediated DNA repair",,-0.396,,-0.396,,.-..,606,684,606.0
kin001-270,gdsc_KIN001-270,Not Clinically Relevant,-0.4,,,-0.4,,-...,607,685,607.0
bms-509744,gdsc_BMS-509744,Not Clinically Relevant,-0.4,,,-0.4,,-...,608,686,608.0
doramapimod,gdsc_Doramapimod,Not Clinically Relevant,-0.40700000000000003,,,-0.407,,-...,611,687,611.0
avagacestat,gdsc_Avagacestat,Not Clinically Relevant,-0.41100000000000003,,,-0.411,,-...,612,688,612.0
pf-4708671,gdsc_PF-4708671,Not Clinically Relevant,-0.414,,,-0.414,,-...,614,689,614.0
a-770041,gdsc_A-770041,Not Clinically Relevant,-0.418,,,-0.418,,-...,615,690,615.0
eht-1864,gdsc_EHT-1864,Not Clinically Relevant,-0.42,,,-0.42,,-...,616,691,616.0
stf-62247,gdsc_STF-62247,Not Clinically Relevant,-0.42100000000000004,,,-0.421,,-...,617,692,617.0
brd-k49290616,ctrp_BRD-K49290616,Not Clinically Relevant,,-0.424,,-0.424,,.-..,618,693,618.0
fti-277,gdsc_FTI-277,Not Clinically Relevant,-0.424,,,-0.424,,-...,619,694,619.0
gsk1904529a,gdsc_GSK1904529A,Not Clinically Relevant,-0.426,,,-0.426,,-...,620,695,620.0
nsc-87877,gdsc_NSC-87877,Not Clinically Relevant,-0.428,,,-0.428,,-...,622,696,622.0
jnk inhibitor viii,gdsc_JNK Inhibitor VIII,Not Clinically Relevant,-0.431,,,-0.431,,-...,623,697,623.0
ci-1040,gdsc_CI-1040,Not Clinically Relevant,-0.43200000000000005,,,-0.432,,-...,624,698,624.0
xmd15-27,gdsc_XMD15-27,Not Clinically Relevant,-0.433,,,-0.433,,-...,625,699,625.0
pha-665752,gdsc_PHA-665752,Not Clinically Relevant,-0.583,,-0.28600000000000003,-0.434,,-.-.,626,700,626.0
selisistat,gdsc_Selisistat,SIRT1 inhibitor,-0.434,,,-0.434,,-...,627,701,627.0
kin001-236,gdsc_KIN001-236,Not Clinically Relevant,-0.435,,,-0.435,,-...,628,702,628.0
jw-7-52-1,gdsc_JW-7-52-1,Not Clinically Relevant,-0.43700000000000006,,,-0.437,,-...,629,703,629.0
sl0101,gdsc_SL0101,Not Clinically Relevant,-0.43799999999999994,,,-0.438,,-...,630,704,630.0
whi-p97,gdsc_WHI-P97,Not Clinically Relevant,-0.439,,,-0.439,,-...,631,705,631.0
fr-180204,gdsc_FR-180204,Not Clinically Relevant,-0.444,,,-0.444,,-...,632,706,632.0
fmk,gdsc_FMK,Not Clinically Relevant,-0.445,,,-0.445,,-...,633,707,633.0
cgp-60474,gdsc_CGP-60474,Not Clinically Relevant,-0.447,,,-0.447,,-...,634,708,634.0
cgp-082996,gdsc_CGP-082996,Not Clinically Relevant,-0.44799999999999995,,,-0.448,,-...,635,709,635.0
xmd8-85,gdsc_XMD8-85,Not Clinically Relevant,-0.449,,,-0.449,,-...,636,710,636.0
cct007093,gdsc_CCT007093,Not Clinically Relevant,-0.452,,,-0.452,,-...,637,711,637.0
z-llnle-cho,gdsc_Z-LLNle-CHO,Not Clinically Relevant,-0.456,,,-0.456,,-...,638,712,638.0
nu7441,gdsc_NU7441,Not Clinically Relevant,-0.456,,,-0.456,,-...,639,713,639.0
xav939,gdsc_XAV939,Not Clinically Relevant,-0.46299999999999997,,,-0.463,,-...,641,714,641.0
cp724714,gdsc_CP724714,Not Clinically Relevant,-0.466,,,-0.466,,-...,642,715,642.0
bix02189,gdsc_BIX02189,Not Clinically Relevant,-0.466,,,-0.466,,-...,643,716,643.0
tak-715,gdsc_TAK-715,Not Clinically Relevant,-0.469,,,-0.469,,-...,644,717,644.0
sb216763,gdsc_SB216763,Not Clinically Relevant,-0.479,,,-0.479,,-...,645,718,645.0
bryostatin 1,gdsc_Bryostatin 1,Not Clinically Relevant,-0.486,,,-0.486,,-...,646,719,646.0
vismodegib,gdsc_Vismodegib,Hedgehog (Smoothened) antagonist (GDC-0449),-0.48700000000000004,,,-0.487,,-...,647,720,647.0
ro-3306,gdsc_RO-3306,Not Clinically Relevant,-0.49200000000000005,,,-0.492,,-...,649,721,649.0
rapamycin,gdsc_Rapamycin,"rapamycin, mTOR inhibitor",-0.496,,,-0.496,,-...,650,722,650.0
681640,gdsc_681640,Not Clinically Relevant,-0.506,,,-0.506,,-...,651,723,651.0
t0901317,gdsc_T0901317,Not Clinically Relevant,-0.51,,,-0.51,,-...,652,724,652.0
motesanib,gdsc_Motesanib,Not Clinically Relevant,-0.511,,,-0.511,,-...,653,725,653.0
pelitinib,gdsc_Pelitinib,Not Clinically Relevant,-0.519,,,-0.519,,-...,654,726,654.0
iox2,gdsc_IOX2,Not Clinically Relevant,-0.52,,,-0.52,,-...,655,727,655.0
cetuximab,gdsc_Cetuximab,Not Clinically Relevant,-0.53,,,-0.53,,-...,656,728,656.0
kin001-260,gdsc_KIN001-260,Not Clinically Relevant,-0.536,,,-0.536,,-...,657,729,657.0
rtrail,gdsc_rTRAIL,Not Clinically Relevant,-0.555,,,-0.555,,-...,659,730,659.0
gnf-2,gdsc_GNF-2,Not Clinically Relevant,-0.557,,,-0.557,,-...,660,731,660.0
y-39983,gdsc_Y-39983,Not Clinically Relevant,-0.5579999999999999,,,-0.558,,-...,661,732,661.0
qs11,gdsc_QS11,Not Clinically Relevant,-0.5589999999999999,,,-0.559,,-...,662,733,662.0
ql-xi-92,gdsc_QL-XI-92,Not Clinically Relevant,-0.5589999999999999,,,-0.559,,-...,663,734,663.0
az628,gdsc_AZ628,Not Clinically Relevant,-0.565,,,-0.565,,-...,664,735,664.0
idelalisib,gdsc_Idelalisib,"Idelalisib,  PI3K/p110δ inhibitor",-0.5660000000000001,,,-0.566,,-...,665,736,665.0
vx-11e,gdsc_VX-11e,Not Clinically Relevant,-0.5720000000000001,,,-0.572,,-...,666,737,666.0
pd173074,gdsc_PD173074,Not Clinically Relevant,-0.5770000000000001,,,-0.577,,-...,667,738,667.0
wz-1-84,gdsc_WZ-1-84,Not Clinically Relevant,-0.594,,,-0.594,,-...,668,739,668.0
cyclopamine,gdsc_Cyclopamine,Not Clinically Relevant,-0.617,,,-0.617,,-...,669,740,669.0
vnlg/124,gdsc_VNLG/124,Not Clinically Relevant,-0.62,,,-0.62,,-...,670,741,670.0
nutlin-3a (-),gdsc_Nutlin-3a (-),Not Clinically Relevant,-0.623,,,-0.623,,-...,671,742,671.0
gw441756,gdsc_GW441756,Not Clinically Relevant,-0.6459999999999999,,,-0.646,,-...,672,743,672.0
